Proximal humerus fractures: clinical guidelines

Applies toadults, children2024 editionS42.2, S42.7, S42.8, S42.9…

Clinical guidelines of the Russian Ministry of Health, adults, children. 2024 edition, ICD-10 codes: S42.2, S42.7, S42.8, S42.9…. This page features a condensed version by WhiteCoat Pro and the full official text.

Receive research articles on "Proximal Humerus Fractures"Every morning — fresh PubMed studies on this topic and specialty: in English, with figures, sample size, and conclusions. Plus updates to Russian clinical guidelines.

Subscribe for 990 ₽

Brief for Practice

WhiteCoat Pro editorial summary based on the 2024 guideline text. Each item links to the original section — verify against it before prescribing.

Proximal humerus fractures include extra-articular and intra-articular injuries of the upper third of the humerus; they most commonly occur after a fall onto an abducted arm. The guideline describes diagnostics, selection of conservative or surgical management, pain control, complication prevention, and rehabilitation in adults and children.

Key points

Diagnostics

  1. A thorough history and symptom review are recommended for diagnostic purposes. LoE C, GoR 5. → in text
  2. Assess somatic status, local signs, blood pressure, temperature, and VTE risk no later than 1 hour after admission. It is recommended to assess peripheral circulation and innervation, as well as soft tissue status and swelling to rule out open fractures, hematomas, and signs of compartment syndrome. Level of confidence C, GoR 5. → in text
  3. Perform radiography of the shoulder and shoulder joint in two projections including the elbow joint; true anteroposterior (AP), scapular Y, and axial projections are used. LoE C, GoR 5. → in text
  4. If an intra-articular fracture is present or suspected, perform a CT scan of the shoulder joint to clarify the fracture line, fragment displacement, and articular surface damage. LoE C, GoR 5. → in text
  5. If a brachial plexus injury (excluding plexopathy) or rotator cuff tear is suspected, perform an MRI of the shoulder joint. LoE C, GoR 5. → in text
  6. If vascular injury is suspected following examination and radiography, perform contrast-enhanced CT angiography or arteriography; additionally, Doppler ultrasound of the limb arteries and veins may be performed. LoE C, GoR 5. → in text
  7. All patients should undergo complete blood count and urinalysis, blood chemistry, blood type and Rh factor, HBsAg, anti-HCV, Treponema pallidum antibodies, HIV-1/2 and p24, coagulogram, and INR. Level of confidence A, GoR 3. → in text

Treatment

When to refer and how to monitor

Frequently asked questions

When can a proximal humerus fracture be managed conservatively?

In the absence of displacement, in impacted fractures, in patients older than 75 years with low physical activity and decreased bone mineral density, and when surgery is declined. In children, age and acceptable displacement limits are taken into account. LoE B, GoR 3. → in text

What displacement threshold is an indication for surgery?

According to the guidelines and Neer's classification, displacement is defined as fragment separation of more than 1 cm or rotational displacement of more than 45°. Significant displacement is included in the criteria for surgical treatment. → in text

When is a CT scan necessary if the fracture is already visible on radiographs?

CT of the shoulder joint is performed when an intra-articular fracture is present or suspected to clarify the nature of the injury, displacement, and condition of the articular surface, including for preoperative planning. LoE C, GoR 5. → in text

How should pain be managed in a patient with this fracture?

Multimodal analgesia with NSAIDs, paracetamol, gabapentinoids, and, if necessary, immediate-release opioids is preferred; the postoperative regimen may include regional anesthesia. Opioids are used in the minimum effective doses and for the shortest possible duration. Level of Reliability of Evidence (LRE) A, Level of Credibility of Data (LCD) 1. → in text

When should rehabilitation be started after surgery?

Following fracture fixation, mobilization and functional recovery are initiated within 24 hours after surgery and no later than 10–14 days from the trauma, following a consultation with a physical and rehabilitation medicine (PRM) physician/exercise therapy specialist. Following arthroplasty, rehabilitation proceeds in stages: 0–3, 3–9, and 9–12 weeks. → in text

Status
Applied · approved by the Scientific and Practical Council of the Russian Ministry of Health
Database ID
859, revision 1 (ID 859_1)
Publication date
December 19, 2024
Age category
adults, children
ICD-10 codes
S42.2S42.7S42.8S42.9S43.0S43.4S43.5S46.0T92.1
Specialties
Traumatology and Orthopedics
Developers
Association of Traumatologists and Orthopedists of Russia
Official text
Russian Ministry of Health Guidelines — 859_1

Shortened Clinical Guidelines: Proximal Humeral Fractures

An abbreviated version of this guideline from WhiteCoat Pro — 32 pages: each section of the document is summarized concisely in plain language, complete with tests and fill-in-the-blanks for self-assessment. Designed for when you need not just to read a guideline, but to master it for an exam, accreditation exam, or clinical practice.
All abbreviated clinical guidelines: 280
Beginning of abbreviated version — open

1. Brief information on the disease or condition

1.1 Definition

Proximal humeral fractures (PHF) represent a non-classified concept combining fractures of the upper third of the humerus.

  • Nature of injury: disruption of bone integrity in the proximal metaepiphyseal region due to trauma.
  • Relation to the joint: can be extra-articular or intra-articular in nature.
  • Features in children: a specific type of fracture is distinguished — epiphysiolysis and osteoepiphysiolysis.
  • By number of fragments: divided into simple and comminuted.

1.2 Etiology and Pathogenesis

PHFs occur due to the impact of a high-energy external traumatic agent.

Classification by injury mechanism:

  • Direct impact: the traumatic force is applied directly to the fracture site.
  • Indirect impact: the traumatic force is applied at a distance from the fracture site.

Classification by injury energy:

  • High-energy fractures:
  • Usually the result of direct trauma.
  • Accompanied by significant damage to surrounding soft tissues.
  • Occur significantly less frequently.
  • Characterized by a complex fracture pattern (often involving damage to the articular surface).
  • Low-energy fractures:
  • Have an indirect mechanism of injury.
  • Typical for patients with reduced bone mineral density.

Key pathogenetic features:

  • The vast majority of PHF cases are the result of low-energy trauma (indirect impact).
  • Most common cause: falling from standing height onto an abducted upper extremity.
  • In newborns: the cause of the fracture (epiphysiolysis of the proximal end of the humerus) is obstetric delivery. This condition is classified as obstetric epiphysiolysis.

1.3 Epidemiology

  • PHFs rank third in frequency of occurrence among all fractures.
  • Account for 4–10% of the total number of fractures.
  • In frequency, they are second only to proximal femoral fractures and fractures of... (text on the page is cut off).

Fracture Epidemiology (PHF)

  • Risk groups: women and elderly individuals are most susceptible.
  • Mean age of victims: 71 years.
  • Incidence rate: 31–250 cases per 100,000 population per year.
  • Dynamics: an increase in the incidence of trauma is noted due to the growing proportion of the elderly population.

ICD-10 Coding

  • S42.2 – Fracture of upper end of humerus.
  • S42.7 – Multiple fractures of clavicle, scapula and humerus.
  • S42.8 – Fracture of other parts of shoulder girdle and arm.
  • S42.9 – Fracture of shoulder girdle, part unspecified.
  • S43.0 – Dislocation of shoulder joint.
  • S43.4 – Sprains and strains of capsule-ligamentous apparatus of shoulder joint.
  • S43.5 – Sprains and strains of acromioclavicular joint.
  • S46.0 – Injury of muscle and tendon of rotator cuff of shoulder.
  • T92.1 – Sequelae of fracture of upper extremity, excluding wrist and hand.

Classification and Determination of Fracture Localization

For precise anatomical localization, it is necessary to determine the center of the fracture:

  • Simple fracture: the midpoint of the oblique or spiral fracture line.
  • Fracture with a wedge fragment: the widest part of the wedge or the midpoint of the fragmented wedge (determined after reduction).
  • Complex fracture: the midpoint between the proximal and distal borders of the fracture (determined after reduction with restoration of bone length).

Classification of metaepiphyseal fractures:

Divided into two main groups:

  • Extra-articular
  • Intra-articular, which are subdivided into:
  • Incomplete: part of the articular surface remains intact and maintains connection with the undamaged diaphysis.
  • Complete: the entire cross-section of the metaphysical bone is damaged.

Pediatric features:

  • If a growth plate is present, a fracture passing through it is called epiphysiolysis.
The official full text of the guideline below remains open and free. Only the condensed study version as a whole is paid: section-by-section explanations, self-assessment tests, and integration with platform materials.

List of Abbreviations

EFA – external fixation apparatus

AO – Association for Osteosynthesis

VTE – venous thromboembolism

RTA – road traffic accident

CT – computed tomography

HDL – high-density lipoproteins

LDL – low-density lipoproteins

PT – physical therapy

Ministry of Health of the Russian Federation – Ministry of Health of the Russian Federation

MRI – magnetic resonance imaging

LMWH – low-molecular-weight heparin

NSAIDs – nonsteroidal anti-inflammatory drugs from the M01A Non-steroidal anti-inflammatory and antirheumatic products group

PH – proximal humerus

TAT – tetanus antitoxin

HTIG – human tetanus immunoglobulin

SWD – surgical wound debridement

SCT – spiral computed tomography

TIA – transient ischemic attack

RF – risk factors

PRM – physical and rehabilitation medicine

FS – functional status

TENS – transcutaneous electrical nerve stimulation

Surgical antibiotic prophylaxis

LCP – locking compression plate

ORIF – open reduction internal fixation

TEN – titanium elastic nail for children

KW – Kirschner wire

Terms and Definitions

Internal fixation device — an orthopedic implant placed during surgery that connects bone fragments in the treatment of fractures, deformities, or pseudarthrosis.

Bone fragment – a portion of bone separated as a result of trauma, surgery, or a destructive process.

Open fracture – a disruption of bone integrity accompanied by damage to the skin in the fracture area and injury to the surrounding soft tissues.

EFAS – external fixation apparatus: an orthopedic device comprising an implant (a transosseous or extracorporeal element protruding through the skin, reaching or embedded in the bone) and an external (non-implantable) support connecting bone fragments via transosseous elements in the treatment of fractures, pseudarthrosis, or gradual lengthening (correction of deformity) of a segment.

Load – mechanical force applied to a limb, bone, and fixation system during treatment, typically recurring with constant periodicity (cyclically).

Fixation – a state in which relative or complete immobilization of fragments is achieved.

Fixation stability – resistance of the system to external loads, allowing it to maintain the constancy of the mutual orientation of fragments and the optimal distance between them.

Absolute stability – absence of micromotion at the fracture site, provided there is anatomical reduction and interfragmentary bone compression after fixation with hardware.

Migration of fixation elements - the loss of the optimal position of fixation elements due to bone resorption around them, occurring when permissible cyclic loads, their number, or installation technology into the bone are exceeded (within the context of this topic).

Fracture consolidation - the mutual joining of fragments by living bone tissue due to the successful completion of the reparative regeneration process.

Impaired consolidation - changes in reparative bone tissue regeneration manifested by a decrease in the rate or cessation of neo-osteogenesis, leading to the inability to perform the mechanical function of the bone.

Post-traumatic deformity - fracture consolidation with a violation of spatial, including axial and rotational, relationships between fragments.

Autograft - a fragment of the patient's own bone harvested from a donor site for transplantation to replenish a bone tissue deficit (bone defect).

Allograft - a fragment of another person's (donor's) bone tissue, typically cadaveric, that has undergone a preservation procedure.

Contracture – restriction of the range of motion in a joint.

Rotator cuff – a functional group of four muscles and their tendons located deep around the shoulder joint, serving to stabilize and rotate the humerus. The rotator cuff includes: the supraspinatus, infraspinatus, teres minor, and subscapularis muscles.

1. Brief information on the disease or condition

1.1 Definition of the disease or condition

Proximal humerus fractures are a non-classification concept uniting extra-articular and intra-articular fractures of the upper third of the humerus. These fractures represent a disruption of the integrity of the humerus in the proximal metaepiphysis area due to trauma. These injuries can be extra-articular or intra-articular; in children, a special type of fracture is epiphyseolysis and osteoepiphyseolysis. According to the number of fragments, PH fractures are divided into simple and comminuted.

1.2 Etiology and pathogenesis of the disease or condition (group of diseases or conditions)

PH fractures occur as a result of a high-intensity external traumatic agent. Direct and indirect trauma mechanisms are distinguished. In the direct trauma mechanism, force is applied directly to the fracture site. The indirect trauma mechanism is characterized by the fact that the injuring force is applied at a distance from the fracture site. According to the energy of injury, high-energy and low-energy fractures are distinguished. The former are usually the result of direct trauma and are accompanied by significant damage to surrounding soft tissues. Low-energy fractures have an indirect trauma mechanism and occur in patients with reduced bone mineral density. In most cases, PH fractures are the consequence of low-energy trauma and occur due to the indirect action of the injuring agent [1, 2]. The most frequent causes are falls from standing height onto an abducted upper extremity. High-energy PH injuries occur significantly less often and are often characterized by a complex fracture pattern with damage to the articular surface of the humerus. In newborns, the cause of fracture–epiphyseolysis of the proximal end of the humerus is obstetric delivery and is termed obstetric epiphyseolysis of the proximal end of the humerus.

1.3 Epidemiology of the Disease or Condition

PH fractures rank third (4-10% of all fractures) in frequency of occurrence after proximal femur fractures and distal radius fractures. Women and elderly people are most susceptible to this injury – the mean age of victims is 71 years [1, 2, 3, 4]. The incidence of PH fractures ranges from 31 to 250 cases per 100,000 population per year, with an increase noted due to the growing proportion of the elderly population [1].

1.4 Features of Coding the Disease or Condition

ICD-10:

S42.2 – Fracture of upper end of humerus

S42.7 – Multiple fractures of clavicle, scapula and humerus

S42.8 – Fracture of other parts of shoulder girdle and arm

S42.9 – Fracture of shoulder girdle and arm, part unspecified

S43.0 – Dislocation of shoulder joint

S43.4 –Sprain and strain of joint capsule and ligaments of shoulder joint

S43.5 – Sprain and strain of acromioclavicular joint capsule and ligaments

S46.0 – Injury of muscle and tendon of rotator cuff of shoulder

T92.1 – Sequelae of fracture of upper limb, level unspecified

1.5 Classification of the disease or condition

To accurately determine the anatomical location of a fracture, its center must be determined. For a simple fracture, the center is the midpoint of the oblique or spiral fracture line; for wedge fractures, it is the widest part of the wedge or the midpoint of the fragmented wedge after reduction; for complex fractures, the center is determined after reduction with restoration of bone length as the midpoint between the proximal and distal boundaries of the fracture [5].

All metaepiphyseal fractures are divided into extra-articular and intra-articular. Intra-articular fractures, in turn, are subdivided into partial, in which part of the articular surface remains intact and retains connection with the undamaged diaphysis, and complete, in which the entire cross-section of the metaphyseal bone is damaged; in the presence of a growth plate in children, the fracture passes through the growth plate and is called epiphyseolysis.

Diagnosis coding begins with determining the anatomical localization of the fracture: bone and segment. According to the AO classification, the humerus has the number 1. A PH fracture is coded as 11. Then, the morphological characteristics of the fracture are determined. This consists in determining the type, group, and subgroup of the fracture. All fractures are subdivided into 3 types: A, B, and C.

11-A – extra-articular two-fragment PH fracture

11-A1 – fracture of the humeral tuberosity (greater or lesser)

11-A2 – fracture of the surgical neck of the humerus

11-A3 – vertical fracture

11-B – extra-articular three-fragment PH fracture with fracture of the surgical neck

11-B1 – fracture of the surgical neck combined with a tuberosity fracture (greater or lesser)

11-C – intra-articular or four-fragment PH fracture

11-C1 – fracture of the anatomical neck of the PH

11-C3 – fracture of the anatomical neck combined with a complex fracture of the metaepiphyseal part or extending into the diaphysis

Neer's four-fragment classification of PH fractures implies the isolation of 4 fragments in the PH: the humeral diaphysis, greater tuberosity, lesser tuberosity, and the articular surface of the humeral head. Category division is based on the number of displaced PH fragments with additional categories for fracture-dislocations and intra-articular fractures. Displacement is defined as fragment separation of more than 1 cm or rotational displacement of fragments relative to each other of more than 45 degrees.

Neer classification:

One-fragment fracture – none of the fragments meets the displacement criteria. In this case, regardless of the number or location of the PH fracture lines, the fracture is classified as a one-fragment fracture.

Two-fragment fracture – one of the fragments is displaced; this may be the greater tuberosity, lesser tuberosity, or fragment with the articular surface with the fracture line at the level of the surgical or anatomical neck.

Three-fragment fracture – fracture of one of the tuberosities combined with a fracture of the surgical neck of the humerus with rotational displacement of the fragments.

Four-part fracture – displaced fractures with the formation of 4 fragments (both tuberosities, the articular surface, and the diaphyseal shaft). Usually, the articular surface of the humeral head is displaced laterally and dislocated. This injury is accompanied by a high risk of avascular necrosis.

Four-part fracture with valgus impaction – a fracture characterized by the fact that the humeral head is impacted between the tuberosities and assumes a valgus position. This category was added by Neer due to the fact that in this type of fracture, the articular surface of the proximal humerus maintains congruence with the glenoid cavity of the scapula, which determines a prognosis and treatment different from those of a classic four-part fracture.

Fracture-dislocations and fractures of the articular surface of the humeral head – this type of injury is classified into a separate category due to the fact that it is characterized by a high risk of avascular necrosis and heterotopic ossification. Articular surface fractures are subdivided into split fractures and fractures with articular surface impression [6].

For open fractures of the proximal humerus, the classification by R.B. Gustilo, J.T. Anderson (1976) [7] as modified by R.B. Gustilo, R.M. Mendoza, and D.N. Williams (1984) [8] is used:

Type I – open fracture, the wound is minimally contaminated, wound size is less than 1 cm;

Type II – open fracture, the wound is greater than 1 cm and less than 10 cm in length without significant soft tissue damage, flaps, or skin detachment;

Type IIIA – open fracture, soft tissues cover the fragments, no periosteal stripping in the presence of extensive soft tissue damage or flaps, or in high-energy trauma regardless of wound size;

Type IIIB – open fracture with an extensive soft tissue defect, periosteal stripping, and a comminuted fracture pattern, often with significant microbial contamination of the wound;

Type IIIC: open fracture complicated by major vascular injury requiring surgical reconstruction, regardless of the extent of soft tissue damage.

In children, the general Salter-Harris classification of fractures involving the growth plate is used.

1.6 Clinical presentation of the disease or condition

Complaints: pain in the shoulder and/or shoulder joint area, impaired function of the upper extremity, deformation in the upper third of the arm or shoulder joint, pain in the wound area (in open fractures).

Anamnesis: a history of trauma, the patient describes a characteristic mechanism of injury. Most often, the mechanism of injury is indirect – a fall from standing height onto an abducted arm. In rare cases, such an injury may occur in patients with seizure disorders. In high-energy trauma (in case of a traffic accident or a fall from a height), injuries are characterized by greater severity and may be combined with injuries to other body segments or areas; therefore, it is necessary to carefully collect the patient's complaints and perform a physical examination.

Objective status: swelling of the shoulder joint area, smoothing of contours, limitation of active and passive movements due to severe pain syndrome, forced position of the limb; in fracture-dislocations of the proximal humerus, changes in the contours of the shoulder joint and soft tissue depression in the subacromial space are possible; palpation reveals marked tenderness in the upper third of the arm, and crepitus of bone fragments may be present during passive movements.

2. Diagnostics, medical indications and contraindications for diagnostic methods

Criteria for establishing the diagnosis/condition:

  • anamnestic data: history of a characteristic upper extremity trauma mechanism (fall, traffic accident, etc.)

  • physical examination findings: impaired function of the injured segment, local swelling and tenderness in the trauma region (pain exacerbated by axial loading), presence of abnormal mobility and/or fragment crepitus

  • Instrumental examination data: radiographic signs of fracture based on radiography in 2 projections. Additional CT scanning may be performed as prescribed by the on-duty or attending trauma surgeon/orthopedic surgeon to clarify the nature of the fracture and determine the degree of fragment displacement.

2.1 Complaints and Anamnesis

In most cases, patients present with complaints described in Section 1.6 "Clinical Presentation"

It is recommended to thoroughly take complaints and history for diagnostic purposes [1, 19, 129].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

2.2 Physical Examination

Physical examination findings are described in Section 1.6 "Clinical Presentation"

  • The assessment of the following parameters is recommended to be carried out no later than 1 hour after admission to the hospital, with mandatory recording of the results in the medical history:

- Assessment of somatic status;

- Visual and palpation assessment of local status [9, 19, 129].

LEL 5Grade of Recommendation C (Level of Evidence – 5).

- Blood pressure measurement;

- Body temperature measurement;

- Assessment of the risk of venous thromboembolic complications [10].

LEL 5Grade of Recommendation C (Level of Evidence – 5).

It is recommended to assess the state of innervation and blood circulation in the peripheral parts of the limb in order to rule out neurovascular bundle injury at the fracture level [1, 130].

  • Level of Evidence C (reliability of evidence level – 5).

It is recommended to assess the condition of soft tissues and the severity of edema to rule out hematomas, developing compartment syndrome, and open fractures [1, 9, 130].

  • Level of Evidence C (reliability of evidence level – 5).

  • When making a decision on surgical treatment of a fracture in adult patients with proximal humeral fractures, it is recommended to collect a medical history and perform a physical examination to identify risk factors and cardiovascular diseases [11, 12].

LE AQOE 3Level of Evidence A (reliability of evidence level – 3).

Comment: Risk factors for the development of cardiovascular diseases include: arterial hypertension, smoking, dyslipidemia (elevated total cholesterol >4.9 mmol/L and/or LDL cholesterol >3 mmol/L and/or HDL cholesterol <1.0 mmol/L in men, <1.2 mmol/L in women, and/or triglycerides >1.7 mmol/L), diabetes mellitus, family history of cardiovascular disease at a young age (<55 years for men and <65 years for women) [11]. Established cardiovascular disease is understood as: coronary artery disease, cerebrovascular disease, peripheral atherosclerosis, chronic heart failure, pulmonary hypertension, valvular heart disease, cardiomyopathies [12, 13].

  • All adult patients referred for elective surgical treatment of a proximal humeral fracture are recommended to undergo an assessment of the risk of perioperative cardiovascular complications, taking into account the type of planned surgical treatment, regardless of the presence of comorbid pathology [11, 14].

LE AQOE 3Level of Evidence A (reliability of evidence level – 3).

Comments: When surgical treatment is performed for emergency (<6 hours) and urgent (6–24 hours) indications, preoperative risk assessment is not performed.

Minor orthopedic surgeries are associated with a low risk of cardiovascular complications (30-day risk of myocardial infarction or cardiovascular death after surgery is less than 1%). Major orthopedic surgeries are associated with an intermediate (moderate) risk of cardiovascular complications (30-day risk of myocardial infarction or cardiovascular death after surgery is 1-5%) [15].

  • To assess the risk of perioperative cardiovascular complications in adult patients, it is recommended to use a special algorithm (Appendix G2) [15, 16].

BMR BLEL 3Level of recommendation validity B (level of evidence – 3).

  • Elective surgical treatment of a proximal humeral fracture is recommended to be performed without additional examination in adult patients in whom the risk of cardiovascular complications is determined to be low. In adult patients with an intermediate or high perioperative risk of cardiovascular complications, an assessment of functional status is recommended [15, 17].

LE AQOE 3Level of Evidence A (reliability of evidence level – 3).

2.3 Laboratory Diagnostics

  • All patients diagnosed with a proximal humeral fracture are recommended to undergo the following laboratory tests for diagnostic purposes:

- complete blood count (CBC);

- urinalysis;

- general clinical blood chemistry test;

- determination of main ABO blood groups and Rh factor (D antigen);

- hepatitis B surface antigen (HBsAg);

- antibodies to hepatitis C virus (Anti-HCV);

- determination of antibodies to Treponema pallidum in the blood,

- investigation of the level of classes M, G antibodies (IgM, IgG) to human immunodeficiency virus HIV 1/2 and p24 antigen (Human immunodeficiency virus HIV 1/2 + Agp24) in the blood;

- coagulogram (exploratory hemostasis test);

- determination of the international normalized ratio (INR) [18, 19].

QOE 3Level of Evidence A (reliability of evidence level – 3).

  • When deciding on surgical treatment of a proximal humeral fracture in adult patients, it is recommended to test the blood level of NT-proBNP in cases of intermediate or high risk of cardiovascular complications and low functional status (see Appendix B2) [11, 13, 15, 20, 21].

QOE 2Level of Evidence A (reliability of evidence level – 2).

2.4 Instrumental Diagnostics

  • Patients with a proximal humeral fracture are recommended to undergo radiography of the upper extremity and shoulder joint in two projections (arm and shoulder joint in two projections including the elbow joint) for diagnostic purposes [1, 22, 130].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: Performing radiography of the shoulder capturing two joints is necessary to diagnose a proximal humeral fracture (PHF), determine the fracture pattern and the degree of fragment displacement, and rule out injury to the segment at other levels. The radiographic examination must include radiographs in the true anteroposterior view (where the patient is turned 30 degrees toward the injured shoulder), scapular Y-views (with the patient positioned with the injured side against the cassette and back to the beam, with a 30-degree angle between the frontal plane and the beam), and an axial view [1, 15]. After confirming the PHF using diagnostic imaging, the patient should be hospitalized in an inpatient facility if indicated; if there are no indications for hospitalization, the patient may be discharged for outpatient treatment at their place of residence.

If a patient refuses inpatient treatment, the reason for refusal must be documented in the inpatient medical record with the signature of the patient or their legal guardians (in cases of legally established incapacity).

  • Patients with a PHF are recommended to undergo computed tomography of the shoulder joint in the presence of or suspicion of an intra-articular PHF to clarify the diagnosis and the nature of fragment displacement [1, 22, 130].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: Spiral CT provides the traumatologist with additional information about the fracture pattern, the degree of fragment displacement, and the severity of articular surface damage, thereby significantly improving the quality of preoperative planning.

  • Patients with a PHF are recommended to undergo magnetic resonance imaging of the shoulder joint (single joint) in the presence of or suspicion of brachial plexus injuries (excluding plexopathy) as well as other soft tissue injuries, such as rotator cuff tears [23, 24, 130].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

  • Patients with a PHF are recommended to undergo computed tomography angiography of the upper extremity (shoulder) vessels with intravenous contrast or shoulder arteriography (upper extremity artery angiography) if physical examination following shoulder and shoulder joint radiography suggests vascular injury [23].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

  • Patients with a proximal humeral fracture are recommended to additionally undergo Doppler ultrasound of the upper extremity vessels (arteries and veins) if vascular injury of the upper extremity is suspected [23, 130].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

  • Adult patients with a PHF are recommended to undergo an ECG to rule out acute coronary syndrome, cardiac arrhythmias, and conduction disorders [25].

LEL 5Grade of Recommendation C (Level of Evidence – 5).

It is recommended to record an ECG for all patients over 65 years of age, as well as for all individuals with risk factors or established cardiovascular disease, regardless of age, if surgical treatment of a PHF with intermediate risk of cardiovascular complications (major orthopedic surgery) is planned [11, 26].

QOE 3Level of Evidence A (reliability of evidence level – 3).

It is recommended to record an ECG daily for 48 hours after emergency or urgent surgical treatment of a PHF in all patients over 65 years of age, as well as in individuals with established cardiovascular disease regardless of age [13, 27].

LE 3Recommendation Grade B (Level of Evidence – 3).

It is recommended to record an ECG daily for 48 hours after elective surgical treatment of a PHF in all adult patients in cases of intermediate or high risk of cardiovascular complications and low functional status of the patient, if the NT-proBNP level was not determined before surgery or its value exceeded 300 pg/mL (see Appendix B2) [13, 28].

It is recommended to perform echocardiography before planned surgical treatment of a PHF in adult patients with low functional status, elevated NT-proBNP levels, left ventricular systolic dysfunction, cardiomyopathies, heart defects, newly detected heart murmurs, and suspected cardiovascular disease [19, 29, 30].

LE 3Recommendation Grade B (Level of Evidence – 3).

2.5 Other Procedures

It is recommended to consider the following indications for consultations with allied specialists in clinical practice:

- neurosurgeon consultation: in case of nerve injury or suspected nerve injury and concomitant head trauma, for children in a multidisciplinary hospital setting;

- neurologist consultation in children: in case of nerve injury or suspected nerve injury or concomitant head trauma;

- surgeon consultation: in case of suspected or objectively diagnosed concomitant abdominal trauma;

- pediatric surgeon consultation for children: in case of suspected or objectively diagnosed concomitant abdominal and/or chest trauma;

- vascular surgeon consultation: in case of concomitant vascular injury or suspected vascular injury for a multidisciplinary hospital;

- pediatrician consultation: in the presence of comorbid pediatric conditions (according to the child's medical history);

- therapist consultation: in the presence of comorbid internal medicine conditions (according to medical history) [31, 129].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

  • Before surgical treatment of a PHF, it is recommended to consult a general practitioner/cardiologist or anesthesiologist-resuscitologist to rule out acute or unstable cardiovascular conditions and assess perioperative cardiovascular risk [19, 129].

RG CLE 5Recommendation Grade C (Level of Evidence 5).

  • Before surgical treatment of a PHF, it is recommended to consult a cardiologist for patients with ECG abnormalities and/or elevated NT-proBNP levels if they are determined to be at high perioperative risk and have low functional status [15].

RG CLE 5Recommendation Grade C (Level of Evidence 5).

  • If acute or unstable clinical conditions are identified, it is recommended to postpone elective surgical treatment of a PHF until the patient's cardiac status improves and condition stabilizes; transfer of the patient to a regional vascular center or specialized cardiology department is indicated [15].

GCR CLOE 5Grade of Recommendation C (Level of Evidence – 5).

3. Treatment, including drug and non-drug therapies, diet therapy, and pain management

3.1 Conservative Treatment

  • Patients with PHFs upon admission to the hospital are recommended the following minimum scope of care in the admission department:

  • ensuring thermal comfort for the patient;

  • adequate pain management;

  • immobilization of the injured upper extremity;

  • correction of fluid and electrolyte imbalances [1, 19, 25, 129].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

It is recommended to use conservative treatment in cases of undisplaced PHF, impacted PHF, displaced PHF in patients older than 75 years with low motor activity and decreased bone mineral density, or upon the patient's voluntary refusal of surgery, as well as in undisplaced or acceptably displaced fractures in children, taking age into account [1, 2, 130, 131].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

Comments: In 84% of cases, patients with PHFs do not require surgical treatment [1, 2, 32].

It is recommended, if conservative treatment is chosen, to immobilize the injured extremity with a plaster splint, sling, or Desault bandage [2, 31, 130, 132].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

Comments: In modern scientific literature, authors emphasize the importance of early functional movements in the joints of the injured extremity while ensuring that secondary fragment displacement is absent [31].

When immobilizing with a sling, the upper extremity should be placed in a neutral rotation position, as this position reduces the risk of bone fragment displacement and, consequently, patients demonstrate better functional outcomes [2].

It is recommended as part of conservative treatment to perform regular follow-up radiographs of the injured segment (humerus/humeral head radiography) in two projections to monitor fracture healing and the position of bone fragments [9].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Pain Management

For adequate pain management, patients with a PHF are recommended to receive multimodal analgesia, which may include NSAIDs from group M01A Anti-inflammatory and antirheumatic products, paracetamol**, gabapentinoids, and immediate-release opioids, or monomodal analgesia if multimodal administration is not feasible [33-40].

GOM ALOE 1Grade of Recommendation A (Level of Evidence – 1).

Comments:

Adequate pain relief must be provided to a patient with a fracture prior to any manipulations and throughout the entire fracture treatment period, the duration of which varies significantly depending on the chosen management strategy. When managing pain in an inpatient setting, it is necessary to take into account the prescriptions administered at the emergency medical care stage. In the acute phase of trauma, to achieve pain control, proper immobilization of the bone fragments must be provided using a vacuum splint, vacuum mattress, or external fixation device.

Among pharmacological strategies, the current consensus is to use multimodal analgesia (MMA), which involves the use of multiple analgesic drugs (opioid and non-opioid) from group N02 (Analgesics) with different mechanisms of action, combined with non-pharmacological interventions targeting the peripheral and/or central parts of the nervous system [25]. This combination provides more effective pain relief by enhancing the effects of various drugs, which in most cases leads to a reduced frequency of prescriptions and/or doses of opioid analgesics. Thus, MMA improves the risk profile of each drug while ensuring synergistic pain control through different drug classes. Postoperative MMA may include psychotherapy, physical therapy, NSAIDs, paracetamol**, gabapentinoids, regional anesthesia (single-shot injection or peripheral nerve catheter placement), local injections, and opioids [35, 36].

In modern scientific literature, authors emphasize the use of the lowest effective doses of opioids for the shortest possible time, avoiding extended-release opioids. As an adjuvant during MMA, a single perioperative administration of #dexamethasone** can be used, which provides a significant reduction in pain [39].

It must be kept in mind that parenteral administration of most NSAIDs (ketorolac**, diclofenac**) is limited to a maximum of two days, which requires timely switching the patient to oral administration, changing the drug, or approving further use with a medical committee. The specific choice of local anesthesia technique and medications is made by the attending physician individually, in accordance with the patient's characteristics, local protocols, and the medical organization's equipment.

When prescribing analgesic therapy for children, a single dose should be chosen taking into account the child's weight and age. Preference should be given to analgesics with oral or rectal administration routes, avoiding intramuscular injections.

When prescribing analgesic therapy for children, a single dose should be chosen taking into account the child's weight and age. Preference should be given to analgesics with oral or rectal administration routes, avoiding intramuscular injections.

In children with fractures of the proximal humerus, the use of paracetamol** and ibuprofen** is recommended for analgesia [133].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

In children with severe pain and lack of efficacy from paracetamol** and ibuprofen**, the use of other non-steroidal and narcotic analgesics is recommended if appropriate indications are present and contraindications are absent [133].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

It is recommended to perform a local block or regional anesthesia as part of the postoperative multimodal regimen [35, 41].

GPP ALOE 1Grade of Recommendation A (Level of Evidence – 1).

Comments: Recommended analgesic drugs are listed in Appendices A3.1–A3.3.

Prevention of venous thromboembolic events

Routine pharmacological prophylaxis of venous thromboembolism (VTE) is not recommended for patients undergoing surgery for proximal humerus fractures under local or regional anesthesia [42].

Level of Evidence BLevel of Confidence 2Level of recommendation B (level of evidence – 2).

It is recommended to consider perioperative VTE prophylaxis in cases where general anesthesia or tourniquet time exceeds 90 minutes for upper extremity interventions, if the surgery may significantly impair the patient's mobility, or if there is a history of VTE episodes [43].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: The incidence of VTE is 0.64% following surgeries for proximal humerus fractures (open reduction and internal fixation or hemiarthroplasty), which makes pharmacological prophylaxis rational for patients at high risk of VTE. Given the growing population of carriers of genetically determined thrombophilias (antithrombin III, protein C, or S deficiency, factor V Leiden mutation, prothrombin G20210A mutation, etc.), the widespread and often uncontrolled use of estrogens, population aging, and the rising incidence of diabetes and other metabolic disorders that increase VTE risk, pharmacological thromboprophylaxis may be advisable when treating patients with additional risk factors for VTE due to shoulder and forearm fractures, as well as extensive upper extremity soft tissue trauma. The final decision is made by the attending physician, taking into account the extent of the injury, the nature of the planned intervention, and additional patient VTE risk factors. Perioperative prescription of low-molecular-weight heparins (LMWH) for these patients according to the regimens and dosages given in Appendix A 3.4 for 7–10 days (until hospital discharge) or for several days until normal/expected mobility is restored may be possible.

Recommended medications and thromboprophylaxis regimens are given in Appendix A3.4.

Issues regarding VTE prevention in trauma and orthopedic patients are discussed in detail in the 2022 guidelines [44] and the 2023 Russian expert recommendations [45].

Features of thromboprophylaxis in pediatric patients

Hospitalized patients older than 6 months are recommended to undergo bleeding and VTE risk assessment within 24 hours of admission [117] and periodically during their hospital stay [118–120].

Leveled Recommendation CLevel of Evidence 5Level of Evidence C (Level of Evidence – 5).

Comment: Validated VTE risk assessment scales have not been developed for pediatric patients, nor have bleeding risk assessment scales for anticoagulant therapy. Therefore, when deciding on VTE prophylaxis, individual bleeding risk factors (Appendix A3.5), VTE risk factors (Appendix A3.6), and the risk-benefit ratio should be considered [121, 123].

For VTE prophylaxis in children, mechanical and pharmacological methods are used.

  • Pediatric patients at high risk for VTE are recommended to be considered for prophylactic doses of UFH or LMWH [119, 125, 126].

GCP BLeE 3Level of recommendation confidence B (level of evidence reliability – 3).

Comment: For pediatric patients, the use of LMWHs from group B01AB is preferred [125, 126] (preferably #Enoxaparin [123]), but currently, the use of all LMWHs is contraindicated in children in Russia; therefore, their prescription is possible only by decision of a medical committee (prescription “ off label”). Some foreign guidelines mention the use of direct oral anticoagulants (#rivaroxaban**) for VTE prophylaxis in children [123], but currently, there is insufficient clinical evidence of their efficacy and safety in this patient category [122, 124].

To decide on pharmacological VTE prophylaxis, a consultation with a pediatrician or hematologist experienced in treating thrombosis in children is recommended. When prescribing anticoagulants to children, it is advisable to monitor general clinical blood test parameters within 48 hours after starting treatment with enoxaparin or heparin [120]. According to indications, anti-Xa levels should be determined 4–6 hours after the administration of #enoxaparin sodium** (target anti-Xa level 0.1–0.3 IU/mL). Routine monitoring of anti-Xa levels is not recommended [127]. Re-checking anti-Xa may be considered if active bleeding or signs of renal dysfunction develop during #enoxaparin sodium** therapy [56]. When prescribing anticoagulants to children, the glomerular filtration rate is calculated using the modified Schwartz formula (http://nephron.com/peds_nic.cgi).

Surgical antibiotic prophylaxis

  • In the surgical treatment of patients with closed proximal humerus fractures, surgical antibiotic prophylaxis (SAP) for surgical site infection by a single preoperative administration of an antibacterial drug is recommended [46].

GCR ALEL 1Grade of Recommendation A (Level of Evidence – 1)

Comments: In accordance with international clinical guidelines for the prevention of surgical site infections [47, 48], the objective of surgical antibiotic prophylaxis (SAP) is to achieve bactericidal concentrations of the antibacterial drug in tissues exposed to microbial contamination during surgery to prevent surgical site infections. The necessity of SAP is determined by the surgical wound class of the upcoming procedure: SAP is not required for "clean" surgical wounds not associated with the placement of orthopedic implants and metal hardware. SAP should be administered: for clean-contaminated and contaminated surgical wounds; for "clean" surgical wounds involving the placement of orthopedic implants and metal hardware. For infected ("dirty") wounds, SAP is not indicated; antibiotic therapy is performed instead.

It is recommended to use first- and second-generation cephalosporins (cefazolin**, cefuroxime**) as the primary drugs for surgical antibiotic prophylaxis in traumatology and orthopedics procedures, with glycopeptide antibiotics (vancomycin**), lincosamides (#clindamycin**) as alternatives in case of beta-lactam antibiotic intolerance [48].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

Comments: For patients with an unremarkable allergic history and without significant risk factors for methicillin-resistant staphylococci carriage, first- and second-generation cephalosporins (cefazolin**, cefuroxime**) are used for SAP, administered intravenously 30 to 60 minutes before skin incision. In case of beta-lactam intolerance, a combination of vancomycin** with one of the fluoroquinolones (ciprofloxacin**, #levofloxacin**) administered over at least 60 minutes starting 2 hours prior to the incision, or #clindamycin** should be prescribed. When significant risk factors for methicillin-resistant staphylococci (MRS) carriage are present, the SAP regimen must include an antibiotic with anti-MRS activity (vancomycin**). In most cases, a single preoperative dose of the antibiotic is sufficient for effective prophylaxis. For prolonged procedures or massive blood loss, an additional intraoperative dose of the antibiotic should be administered (the estimated timing for intraoperative administration is two half-lives after the preoperative dose). Administering an antibiotic after wound closure in the operating room is impractical even if indwelling drains are present.

Single doses of the main antibacterial drugs for SAP in adult traumatology and orthopedic procedures: cefazolin** 2 g (for patient weight ≥120 kg — 3 g), cefuroxime** 1.5 g, #clindamycin** 900 mg, vancomycin** 15 mg/kg as a slow IV infusion, ciprofloxacin** 400 mg, #levofloxacin** 500 mg. [48].

Single doses for children should be calculated based on actual weight in accordance with the attached drug instructions: cefazolin** 30–50 mg/kg, cefuroxime** 50 mg/kg, #clindamycin** 10 mg/kg, vancomycin** 15 mg/kg. The use of fluoroquinolones during the period of bone and joint system formation when growth plates are open is contraindicated due to the risk of arthropathy development [48].

It is recommended to administer antibacterial therapy to patients with open fractures for a duration of no more than 72 hours after wound closure [49].

GCR ALEL 1Grade of Recommendation A (Level of Evidence – 1)

Comments: In cases of open fractures, prophylactic antibiotic administration is effective in preventing early infection. Antibiotics should be administered as soon as possible after the injury; the antibiotic of choice is cefazolin**. However, for patients with open high-energy fractures with displacement and segmental bone loss; major vascular injury; or heavily contaminated wounds, it is advisable to broaden the spectrum of administered antibiotics to cover Gram-negative pathogens. In such cases, adding #gentamicin** (at a dose of 6 mcg/kg once daily) to cefazolin** may be considered [50, 51]. An alternative to this combination in adults can be #ampicillin+sulbactam** (at a dose of 3.0 g every 8 hours for 3 days) [52], with the latter being particularly relevant in case of a risk of clostridial infection. According to the majority of researchers, in Gustilo–Anderson type III open fractures, antibiotics should not be continued for more than 72 hours after soft-tissue wound closure [53].

Blood-saving techniques

It is recommended for all patients at risk of bleeding during surgical treatment of proximal humeral fractures to use perioperative tranexamic acid** (intravenous solution) for the prevention of bleeding [54, 55, 137].

GOR ALE 2Grade of Recommendation A (Level of Evidence – 2).

Comments: Tranexamic acid** effectively reduces blood loss and leads to a smaller decrease in postoperative hemoglobin levels in patients undergoing surgery for proximal humeral fractures. This effect is observed both in fracture osteosynthesis and shoulder arthroplasty. Randomized clinical trials in adults demonstrate the efficacy of local subfascial administration of #tranexamic acid** (1.0 g in 10 ml) into the surgical wound area, comparable to intravenous administration of an equivalent dose [56]. In children, tranexamic acid is prescribed in accordance with the instructions for use in patients over one year of age undergoing surgeries with an expected blood loss of at least 10% of the circulating blood volume [138].

It is recommended to prescribe iron supplements in the postoperative period for adult patients who have undergone surgery for fractures, in the presence of laboratory-confirmed iron deficiency anemia, to correct their general condition [57].

GOR ALE 2Grade of Recommendation A (Level of Evidence – 2)

Comments: Systematic reviews and meta-analyses demonstrate that perioperative administration of intravenous iron preparations, specifically ferric carboxymaltose**, in trauma and orthopedic patients, particularly in the postoperative period, is an effective alternative to blood transfusion, as it reduces the proportion of patients receiving blood transfusions, decreases the volume of packed red blood cells transfused, and reduces the incidence of infectious complications, without affecting mortality rates [57, 58].

Evidence of the efficacy of intravenous iron preparations for correcting preoperative iron deficiency anemia in elective orthopedic procedures has been obtained in the pediatric population [139, 140]. Data on the use of these drugs in children in the postoperative period following trauma surgeries are lacking.

3.2 Surgical Treatment

It is recommended to perform surgical treatment for patients with proximal humeral fractures in the following cases:

- displaced fractures (according to the Neer classification, fragment displacement of more than 1 cm and angular deformity of more than 45 degrees);

- intra-articular fractures with splitting of the humeral head;

- fractures associated with neurovascular deficits;

- open fractures;

- unstable fractures with damage to the medial cortical layer;

- floating shoulder;

- proximal humeral fractures as part of polytrauma;

- irreducible fracture-dislocations of the proximal humerus;

- in children, epiphyseolysis and osteoepiphyseolysis fractures with displacement following a single failed closed reduction attempt [1, 19, 130, 132].

GCR CLOE 5Grade of Recommendation C (Level of Evidence – 5).

3.2.1 Intramedullary Osteosynthesis

It is recommended to use intramedullary osteosynthesis for two-part displaced proximal humeral fractures using a sterile*** or non-sterile*** intramedullary humeral nail, sterile*** or non-sterile*** non-absorbable orthopedic bone screws. This method is also acceptable in adolescents with low growth potential or closed growth plates [1, 60, 62].

GPP CLOE 4Grade of Recommendation C (Level of Evidence – 4).

Comments: Intramedullary osteosynthesis is a minimally invasive surgical fixation technique for proximal humeral fractures. It is applicable when closed reduction of bone fragments and their maintenance in an anatomical position throughout the procedure are feasible. This technique minimizes soft tissue trauma and disruption of local blood supply [1]. Modern intramedullary implants for proximal humerus allow for osteosynthesis of three- and four-part proximal humeral fractures in selected cases, although fractures of the surgical neck of the humerus in young patients remain the traditional indication [59].

In children, it is permissible to use flexible intramedullary nails crossing the growth plate with subsequent removal after 3–6 months; Kirschner wires can also be used for fragment stabilization.

It is not recommended to use intramedullary osteosynthesis for intra-articular proximal humeral fractures (PHF) with head-splitting, or for three- and four-part displaced PHF [1].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

3.2.2 Percutaneous osteosynthesis

It is recommended to use percutaneous osteosynthesis with threaded Kirschner wires for PHF in adults and children [59].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: Indications for percutaneous fixation of PHF include two-part fractures of the surgical neck of the humerus, greater or lesser tuberosity fractures, three-part fractures combined with injury to one of the tuberosities, and four-part impacted valgus fractures. Prerequisites for stable percutaneous fixation are satisfactory fragment alignment after closed reduction, good bone quality, and an intact medial cortical layer. This osteosynthesis method requires patient monitoring in the early postoperative period and supervision of limb immobilization [59].

Osteosynthesis is performed using threaded wires inserted in various directions to fix the bone fragments [59].

Biomechanical studies have demonstrated that percutaneous fixation provides lower stability of bone fragments compared to open reduction and internal

fixation (ORIF); however, this can be compensated for by using larger-diameter wires and increasing the number of wires inserted in different directions [59]. This circumstance likely accounts for the higher complication rate (28.4%) observed with percutaneous fixation compared to alternative surgical treatments for PHF (ranging from 11.3% to 18.9%) [59].

It is not recommended to use percutaneous osteosynthesis for intra-articular PHF with humeral head-splitting, or for complex PHF with loss of medial cortical stability [1].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

3.2.3 Plate osteosynthesis

It is recommended to use plate osteosynthesis for PHF utilizing a bone fixation plate with screws, non-absorbable, sterile***, a bone fixation plate with screws, non-absorbable, non-sterile***, orthopedic bone screws, non-absorbable, sterile***, orthopedic bone screws, non-absorbable, non-sterile***; their use is also acceptable taking into account the activity of the growth plate and the child's age [1, 32, 59].

For the pediatric population – Level of recommendation C (Level of evidence 5)

For the adult population – Level of recommendation B (Level of evidence 3)

Comments: The development of implants for extra-articular osteosynthesis and the introduction of plates with angular screw stability have made this method of surgical treatment the current method of choice for managing patients with displaced two-, three-, and four-part proximal humeral fractures [59]. The use of angular-stable implants provides more reliable fragment fixation in cases of reduced bone mineral density. In addition, the insertion of a so-called "calcar" screw with angular stability (passing into the humeral head in the area of the medial cortical layer) reduces the risk of varus deformity and improves functional outcomes [1, 63]. When applying the plate to the bone, care must be taken to ensure that the implant is not positioned too high, as this can lead to impingement syndrome, whereas a too-low position results in inadequate fixation of the humeral head and instability [59]. The correct plate position is considered to be: 5–8 mm distal to the apex of the greater tuberosity; the plate axis parallel to the shaft axis of the humerus; 2–4 mm posterior to the bicipital groove of the long head of the biceps [1].

3.2.4 Hemiarthroplasty

It is recommended to use hemiarthroplasty for proximal humeral fractures in middle-aged and elderly patients with severe three- and four-part fractures using an uncapped proximal humeral endoprosthesis stem***, a stem-fixed humeral head endoprosthesis***, a press-fit proximal humeral endoprosthesis stem***, a humeral head endoprosthesis insert***, a humeral endoprosthesis centering device***, and an anchor-type humeral joint endoprosthesis head*** [1, 59, 63].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: Hemiarthroplasty is a technically demanding surgical procedure. When compared with hemiarthroplasty, ORIF demonstrates higher functional outcomes and patient satisfaction rates. This is primarily true for three-part fractures. As Neer's studies showed back in 1970, in the case of four-part proximal humeral fractures, plate fixation fails in 100% of cases, although angular-stable plates with better fixation capabilities were not available at that time. At the same time, hemiarthroplasty allowed the authors to achieve good and excellent results in 96.9% and 73% of patients with three- and four-part proximal humeral fractures, respectively [64, 65]. It is also worth noting that the complication rate is higher with plate osteosynthesis of complex four-part proximal humeral fractures than with arthroplasty [59].

The authors cite preserved function of the rotator cuff and anatomical restoration of the humeral tuberosities as the key to a successful outcome of proximal humeral endoprosthesis replacement [1, 64].

It is recommended to use hemiarthroplasty for proximal humeral fractures in patients with severe intra-articular four-part fractures involving splitting of the humeral head and fracture-dislocations, using an uncapped proximal humeral endoprosthesis stem***, a stem-fixed humeral head endoprosthesis***, a press-fit proximal humeral endoprosthesis stem***, a humeral head endoprosthesis insert***, a humeral endoprosthesis centering device***, and an anchor-type humeral joint endoprosthesis head*** [1, 19, 130, 131].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: Hemiarthroplasty is indicated in cases of high risk of ischemia in damaged bone fragments and subsequent avascular necrosis of the bone tissue. Risk factors for this include damage to the medial cortical layer with fragment displacement and four-part proximal humeral fracture-dislocations [64].

Functional outcomes of treating patients with proximal humeral fractures using hemiarthroplasty are controversial. Mighell et al. [67] report that 93% of patients were pain-free in the postoperative period and satisfied with the treatment outcome. However, a number of authors report the opposite. Boileau et al. [66] report that 42% of patients demonstrated unsatisfactory functional outcomes after hemiarthroplasty. Boons et al. [68] conclude in their study that there are no significant differences in functional outcomes between patients who underwent hemiarthroplasty and patients with four-part proximal humeral fractures treated conservatively. Therefore, the surgeon must always keep in mind the potential risk of a significant decrease in shoulder function in the patient after joint replacement [64].

It is not recommended to use hemiarthroplasty in elderly patients with proximal humeral fractures combined with comminuted fractures of the humeral tuberosities when restoration of the rotator cuff is impossible; in patients with proximal humeral fractures when there are indications for osteosynthesis; in cases of significant impairment of rotator cuff function [1]

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

3.2.5 Reverse Shoulder Arthroplasty

It is recommended to use reverse shoulder arthroplasty for proximal humeral fractures in elderly patients with severe three- and four-part fractures and fracture-dislocations, when performing revision procedures for non-unions and malunions of proximal humeral fractures, or metalwork migration after osteosynthesis, using a glenoid shoulder endoprosthesis component***, a total reverse shoulder endoprosthesis***, a polyethylene reverse shoulder endoprosthesis cup***, a reverse shoulder endoprosthesis head***, a reverse shoulder endoprosthesis body***, and a metal reverse shoulder endoprosthesis cup*** [1, 59, 69].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: According to numerous scientific publications, patients who undergo reverse shoulder arthroplasty demonstrate functional outcomes similar to those of patients after hemiarthroplasty; however, the need for revision procedures is significantly lower in the case of reverse shoulder arthroplasty [59, 70-73].

It is not recommended to use reverse shoulder arthroplasty for proximal humerus fractures in young patients when indications for osteosynthesis are present [1].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

3.3 Other Treatment

It is recommended for patients with open proximal humerus fractures to administer tetanus toxoid** - 10 IU for tetanus prophylaxis, taking into account age restrictions [82, 83], or tetanus antitoxin**, or human tetanus immunoglobulin** [141], taking into account age restrictions.

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

Comments: In accordance with paragraphs 4156-4157 of the Sanitary Rules and Norms on Prevention of Infectious Diseases (SanPiN 3.3686-21), emergency tetanus prophylaxis is carried out for any injuries involving a violation of the integrity of the skin and mucous membranes. Emergency tetanus prophylaxis is performed up to the 20th calendar day from the moment of injury [82]. The prescription of drugs for emergency tetanus immunoprophylaxis is carried out differentially depending on the availability of documentary confirmation of a preventive vaccination or immunological monitoring data on the intensity of anti-tetanus immunity, as well as taking into account the nature of the injuries.

Emergency tetanus immunoprophylaxis is carried out, taking into account age restrictions, in the form of:

- passive immunization or seroprophylaxis with human tetanus immunoglobulin** (HTIG), or in its absence, tetanus antitoxin** (TAT);

- active-passive prophylaxis, consisting of the simultaneous administration into different parts of the body of human tetanus immunoglobulin** (and in its absence, TAT) and tetanus toxoid** (TT);

- emergency revaccination with tetanus toxoid** (or diphtheria-tetanus toxoid** with a reduced antigen content - Td-toxoid) to stimulate immunity in previously vaccinated individuals [82, 83].

4. Medical Rehabilitation and Sanatorium-Resort Treatment

It is recommended for conservative treatment of proximal humerus fractures to provide outpatient rehabilitation, which includes three periods: early period (2-5 weeks) with fixation of the fracture area using an orthosis or a sling, post-immobilization period (5-8 weeks), and recovery period (9-12 weeks) [84, 87, 88].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

It is recommended for conservative treatment of proximal humerus fractures at the first stage of rehabilitation to implement an individual rehabilitation program, including dynamic movements in joints free from immobilization, isometric exercises for the muscle groups of the shoulder, shoulder girdle, and scapular region, and breathing exercises [18, 87, 88].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

Comments: The program is prescribed by a physical and rehabilitation medicine (PRM) physician / exercise therapy physician and is carried out at home. After 5-6 days, for the period of performing the exercises, the immobilizing bandage is removed, and movements in the elbow joint (possibly with the help of the healthy arm) and pendulum movements with the freely hanging arm in the shoulder joint are performed.

It is recommended for conservative treatment of proximal humerus fractures to provide outpatient rehabilitation (day hospital) according to the programs of the second and third periods with dynamic monitoring by a PRM / exercise therapy physician [84, 87].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

Comments: Depending on the severity of functional impairment in the limb, the PRM / exercise therapy physician decides on the location for further rehabilitation: at home or in a day hospital for more severe dysfunction requiring the combined use of rehabilitation modalities (massage, physiotherapy, mechanotherapy)

It is recommended for conservative treatment of proximal humerus fractures to implement a rehabilitation program for the second and third periods using: self-assisted exercises, free exercises, exercises using pulleys; simple mechanotherapy; passive mechanotherapy for the shoulder joint; exercises to restore muscle strength and train hand movement coordination; general aerobic exercises, and training in self-care [85, 87].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

Comments: The rehabilitation program is tailored individually, taking into account the patient's age, general condition, including cognitive impairment, and the severity of functional impairment in the arm.

It is recommended for conservative treatment of proximal humerus fractures in the second and third periods of rehabilitation to use manual and hardware massage of the shoulder and shoulder girdle regions [86, 25].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

Comments: Massage and physical therapy reduce tissue edema and pain, increase tissue elasticity, and improve microcirculation.

It is recommended that after fixation of a PPHH fracture (intramedullary, percutaneous, and plate osteosynthesis), functional restoration of the upper limb and mobilization of the patient should begin within 24 hours after surgery and no later than 10-14 days after the injury, following consultation with a PRM/exercise therapy physician [1, 75, 89].

BMR BLEL 3Level of recommendation validity B (level of evidence – 3).

Comments: The general objectives of the early postoperative period are the prevention of cardiovascular and pulmonary postoperative complications. Local objectives include reducing soft tissue edema, creating optimal anatomical and physiological conditions for the healing of tissues traumatized during surgery, reducing pain, improving blood circulation in the limb, and preventing joint stiffness.

It is recommended to undergo early rehabilitation (weeks 1–2) and outpatient rehabilitation (6 weeks) after osteosynthesis to restore limb function and self-care abilities [1, 86, 90].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

It is recommended to implement an early rehabilitation program following osteosynthesis, including free dynamic and isometric exercises for the shoulder and shoulder girdle muscles, as well as breathing and aerobic exercises [86].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

It is recommended following osteosynthesis to implement an outpatient rehabilitation program including passive exercises, self-assisted exercises, exercises with objects, mechanical therapy on pulley systems, passive mechanical therapy, and resistance exercises for the shoulder joint and muscle groups of the arm [87].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

It is recommended following osteosynthesis, if control radiographs show signs of fracture consolidation, to include strength exercises, training in daily living and self-care skills, water-based exercises, and therapeutic swimming in the outpatient rehabilitation / day hospital program [99].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

It is recommended following osteosynthesis to use physical therapy modalities aimed at reducing pain and edema, suppressing inflammation, and improving tissue trophic function and metabolism in the surgical area. Physical therapy procedures are indicated in the absence of contraindications, as prescribed by a PRM physician/physical therapist [25, 98-100].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5).

Comments: The early rehabilitation program includes cryotherapy, electroanalgesia, and hardware massage; the outpatient rehabilitation program—after suture removal and in the absence of inflammation in the surgical area—includes manual massage of the shoulder and scapular muscles to improve blood circulation and the functional state of the muscles [1].

It is recommended following shoulder arthroplasty to undergo three rehabilitation periods aimed at restoring the mobility of the new joint, strengthening muscles, and restoring the coordination of movements necessary for normal function of the entire arm: the first period at 0–3 weeks, the second at 3–9 weeks, and the third after 9 weeks postoperatively [91-94].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

Comments: Literature data on the duration of rehabilitation periods are inconsistent; some authors distinguish a fourth period, but the necessity of postoperative rehabilitation is reliably demonstrated.

It is recommended following shoulder arthroplasty to conduct early rehabilitation in the orthopedic department of the hospital and on an outpatient basis while the arm is fixed in an orthosis, utilizing isometric, self-assisted, and breathing exercises for the shoulder joint to reduce edema and improve blood circulation, prevent joint stiffness in the arm, and restore the tone of the shoulder and scapular muscle groups [91, 94-96].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

Comments: Immediately after surgery, the arm is immobilized in an orthosis; the duration of wear and type of orthosis are determined by the operating surgeon based on the individual characteristics of the surgical procedure performed.

The orthosis provides rest to the surgical site, which prevents joint dislocation and helps reduce pain and improve soft tissue healing. At this stage (0–3 weeks), the orthosis is removed only to perform exercises.

Before discharge from the hospital, the patient is consulted by a PRM physician/exercise therapy specialist who formulates an individual rehabilitation program with recommendations regarding the activity regimen and necessary home exercises.

It is recommended following shoulder arthroplasty to conduct the second, outpatient stage of rehabilitation (3–9 weeks postoperatively) aimed at restoring passive joint mobility, gradually restoring active movements, and achieving dynamic shoulder stability [90-92, 94, 95].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

Comments: Rehabilitation is carried out at home or on an outpatient basis under the dynamic supervision of a physical and rehabilitation medicine (PRM) physician / exercise therapy (ET) specialist. Active-assisted and active movements in the shoulder joint are performed within a pain-free range of motion in the sagittal and frontal planes. External rotation is not permitted for 6 weeks. Wearing an orthosis during this period is not mandatory, but is recommended in crowded places, such as public transport or walking in a crowd. The arm can be used for self-care, but nothing heavy should be lifted, except for a cup of coffee and only in front of the body.

It is recommended after shoulder arthroplasty to conduct the third outpatient stage of rehabilitation (9–12 weeks postoperatively) to restore the range of active motion in the joint, shoulder muscle strength, and arm functionality [90, 91, 95, 96].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

Comments: Rehabilitation is carried out at home, on an outpatient basis, or in a day hospital. The program is developed by a PRM/ET physician and includes isotonic, concentric, and eccentric exercises, as well as passive tissue stretching in case of contracture (in patients with normal bone structure and signs of fusion on radiography).

For up to 6 months after surgery, nothing heavier than 3 kg should be lifted. The weight should never be raised above the head, only to eye level while visible. Jerks and sudden pushes are not allowed.

Swimming and table tennis are possible at 4–6 months [97].

It is recommended after shoulder arthroplasty to use physical therapy methods (local cryotherapy, low-level laser skin therapy, transcutaneous electrical nerve stimulation (TENS) to reduce edema and pain during the early rehabilitation stage, and manual massage [massage of the upper extremity, shoulder girdle, and scapular region] to improve blood circulation and the tone of the shoulder and scapular muscles during the third rehabilitation stage) [25, 93, 94].

Level CLevel 5Level of recommendation evidence C (reliability level of evidence – 5).

It is recommended after shoulder arthroplasty to follow methodological guidelines for performing physical exercises to prevent joint instability and postoperative fractures, as well as to accelerate recovery times [90–95].

GPP BLOE 3Grade of Recommendation B (Level of Evidence – 3).

Comments:

Methodological guidelines for performing physical exercises are as follows:

- early initiation of exercise;

- slow execution pace with fixation at end-range positions and maximum possible muscle involvement and soft tissue stretching;

- use of active exercises only with progressive resistance: active-assisted, in simplified conditions, using pulley and other mechanotherapy devices, active free exercises, active exercises with additional resistance, isometric, static, and against resistance;

- abduction in the shoulder joint must always be performed in the plane of the scapula.

passive mechanotherapy and complex combined movements, especially taking the arm behind the back, are not used in the initial stages of rehabilitation

- exercise may cause discomfort, but must never cause pain;

all exercises are performed daily, 4–5 times a day; each exercise is repeated 5–10 times.

5. Prevention and Dispensary Observation

Prevention of humeral fractures consists in citizens observing social safety rules when performing household chores, being in traffic zones, walking on poor-quality pavement, and during icy conditions.

A significant share of responsibility in fracture prevention also belongs to state structures, which are obliged to ensure safety to prevent road traffic injuries, as well as ensure compliance with safety regulations in industries with increased risk of trauma.

It is recommended after discharge from the hospital to be referred to an orthopedic traumatologist, pediatric surgeon, or surgeon at an outpatient polyclinic medical institution at the place of residence for dynamic follow-up and continuation of treatment [76].

GCR CLOE 5Grade of Recommendation C (Level of Evidence – 5).

Comments: Upon discharge from the hospital, the patient must be referred to a trauma center or outpatient traumatology department, indicating the treatment provided and detailed recommendations for the continuation of treatment and rehabilitation. This will ensure continuity between the inpatient and outpatient stages of treatment.

Follow-up examinations with radiography of the humerus / humeral head and assessment of functional recovery dynamics are performed at 6–8 weeks postoperatively (assessment of fracture consolidation and the possibility of full limb loading in extra-articular fractures), 12 weeks postoperatively (assessment of fracture consolidation and the possibility of limb loading in intra-articular fractures), 24 weeks postoperatively (assessment of functional recovery dynamics), and 1 year postoperatively (assessment of the functional outcome of treatment and deciding on the need and timing of implant removal. In children, the timing of implant removal is considered depending on whether implants cross the growth plate or not, as well as age, following adult principles after 15 years of age).

6. Organization of Medical Care

Clinical application of recommendations: Traumatology and Orthopedics, Anesthesiology and Intensive Care, Medical Rehabilitation, Healthcare Organization and Public Health, Pediatric Surgery.

Purpose of clinical recommendations: Clinical recommendations have been developed to improve the quality of medical care and standardize diagnostic and treatment algorithms for patients with proximal humeral fractures.

Indications for planned hospitalization:

unsatisfactory result of conservative treatment: absence of signs of proximal humeral fracture consolidation after conservative treatment or osteosynthesis surgery within 2.5–3.5 months after trauma or surgery [1, 49].

Indications for emergency hospitalization:

Patients with suspected or confirmed proximal humeral fractures must be referred to a hospital to decide on the need for emergency hospitalization. Indications for emergency hospitalization are:

- fracture with significant displacement, i.e., fragment displacement of more than 1 cm, angular deformity of more than 45 degrees;

- intra-articular proximal humeral fractures with head splitting or articular surface impression;

- pathological proximal humeral fracture;

- combination of proximal humeral fracture with vascular or neurological disorders;

- open proximal humeral fracture;

- proximal humeral fracture as part of polytrauma;

- ipsilateral fractures of the proximal humerus and other upper extremity segments;

- flail shoulder;

- fracture-dislocation in children.

Indications for patient discharge from the hospital:

1. Internal fixation of the fracture with hardware, shoulder arthroplasty, or adequate plaster immobilization for conservative treatment has been performed.

2. The first stage of rehabilitation has been completed.

3. There is no acute infectious process.

4. Refusal of the patient or their legal guardians (in case of legally established patient incapacity) to continue inpatient treatment (the reason for refusal must be documented in the medical history with the personal signature of the patient or their guardians).

7. Additional Information

To assess treatment outcomes in patients with fractures at the shoulder girdle and arm level, questionnaires have been developed to evaluate the functional result of treatment.

1) Disabilities of the Arm, Shoulder, and Hand (Disabilities of the Arm, Shoulder, and Hand, DASH) questionnaire was developed jointly by the American Academy of Orthopaedic Surgeons, the Council of Musculoskeletal Specialty Societies, and the Institute for Work and Health (Canada). It belongs to patient-reported outcome measures and was introduced in 1996 for the standardized assessment of the impact of various musculoskeletal injuries and diseases on upper extremity function [101]. DASH is a 30-item questionnaire with response options presented as a 5-point Likert scale. Scores range from 0 (no functional limitations) to 100 (most severe functional limitations). The questionnaire is intended for patients with any upper extremity musculoskeletal disorders [102]. DASH has two optional modules (four items each) designed for athletes, musicians, and workers whose activities require special physical conditioning and whose functional limitations may only arise under high loads exceeding the scope of the 30 DASH items. Approved translated versions of DASH in 56 languages and dialects, including Russian, are available on the website of the Institute for Work and Health (Canada), which holds the copyright for the questionnaire (https://dash.iwh.on.ca/available-translations).

2) The Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH) is an 11-item shortened version of the DASH questionnaire with the same response options [103, 104]. Like DASH, it is designed for patient self-assessment of upper extremity function in various diseases and injuries. QuickDASH also features two optional modules (four items each) intended for athletes, musicians, and workers whose activities require specific physical conditioning, where functional limitations may only appear at high exertion levels exceeding the 11 items of the QuickDASH. The optional modules are evaluated separately. In a number of studies, comparing the DASH and QuickDASH questionnaires showed that both instruments have approximately equal sensitivity, specificity [105–109], and minimal clinically important difference (12–14 points for DASH and 12–15 points for QuickDASH) [110]. In a systematic review of 23 self-assessment instruments for patients with various upper extremity pathologies, the QuickDASH demonstrated the highest content and construct validity, reliability, and responsiveness [111]. There are reports of successful use of QuickDASH in children aged 8–18 years [112, 113]. Approved translation versions of QuickDASH in 56 languages and dialects, including Russian, are available on the website of the Institute for Work & Health (Canada), which holds the copyright (https://dash.iwh.on.ca/available-translations).

The Russian translation of the QuickDASH in its original version is provided in Appendix G1.

Criteria for Evaluating the Quality of Medical Care

№

Quality criteria

Performance assessment (yes/no)

1

Examination by an orthopedic trauma surgeon performed no later than 1 hour from admission to the inpatient facility

Yes/no

2

Radiography of the humerus and humeral head performed upon admission to the inpatient facility

Yes/no

3

Analgesia administered no later than 30 minutes from admission to the inpatient facility (in the absence of medical contraindications)

Yes/no

4

Computed tomography of the upper extremity and joint and/or magnetic resonance imaging of the joints (one joint) performed

(for intra-articular fractures)

Yes/no

5

Reduction and stabilization of the fracture achieved by the time of discharge from the inpatient facility (according to medical indications)

Yes/no

References

Show references
  1. Buckley R.E., Moran C.G., Apivatthakakul T. AO principles of fracture management. 3rd ed. In 2 vol. Georg Thieme Verlag, 2017.

  2. Launonen A.P., Lepola V., Saranko A. et al. Epidemiology of proximal humerus fractures. Arch. Osteoporos. 2015; 10: 209.

  3. Joyce C.D., Seidl A., Boileau P. Concept of neutral rotation sling for non-operative treatment of proximal humerus fractures. Ann. Joint. 2021; 6 (17): URL: https: //aoj.amegroups.org /article/view/5915.

  4. Xie L., Ding F., Zhao Z. et al. Operative versus nonoperative treatment in complex proximal humeral fractures: a meta-analysis of randomized controlled trials. Springerplus, 2015; 4: 728.

  5. Meinberg E.G., Agel J., Roberts C.S. et al. Fracture and Dislocation Classification Compendium-2018. J. Orthop. Trauma. 2018; 32 (Suppl.1): S1-S170.

  6. Carofino B.C., Leopold S.S. Classifications in brief: the Neer classification for proximal humerus fractures. Clin. Orthop. Relat. Res. 2013; 471 (1): 39-43.

  7. Gustilo R.B., Anderson J.T. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J. Bone Joint Surg. Amer. 1976; 58 (4): 453-458. 

  8. Gustilo R.B., Mendoza R.M., Williams D.N. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984; 24 (8): 742-746.

  9. Kotelnikov G.P., Mironov S.P., Miroshnichenko V.F. Traumatology and Orthopedics: Textbook. Moscow: GEOTAR-Media, 2009. 400 p.

  10. Bozhkova S.A., Bulanov A.Yu., Vavilova T.V. et al. National Standard of the Russian Federation. GOST R 56377-2015 Clinical Guidelines (Treatment Protocols) Prevention of Thromboembolic Syndromes. Problems of Standardization in Healthcare. 2015; (7-8): 28-68.

  11. Halvorsen S., Mehilli J., Cassese S. et al.; ESC Scientific Document Group. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022; 43(39): 3826-3924.

  12. Botto F., Alonso-Coello P., Chan M.T. et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014; 120: 564–578

  13. Duceppe E., Parlow J., MacDonald P. et al.; Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can. J. Cardiol. 2017; 33(1): 17-32.

  14. Glance L.G., Lustik S.J., Hannan E.L. et al. The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann. Surg. 2012; 255: 696–702

  15. Sumin A.N., Duplyakov D.V., Belyalov F.I. et al. Guidelines for the assessment and correction of cardiovascular risks in non-cardiac surgery. Russ. J. Cardiol. 2023; 28 (8): 5555.

  16. Fronczek J., Polok K., Devereaux P.J. et al. External validation of the Revised Cardiac Risk Index and National Surgical Quality Improvement Program Myocardial Infarction and Cardiac Arrest calculator in noncardiac vascular surgery. Br. J. Anaesth. 2019; 123 (4): 421–429.

  17. Snowden C.P., Prentis J.M., Anderson H.L. et al. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Ann. Surg. 2010; 251: 535–41

  18. Munro J., Booth A., Nicholl J. Routine preoperative testing: a systematic review of the evidence. Health Technol. Assess. 1997; 1 (12): 1–62.

  19. Klyuchevsky V.V. Surgery of Injuries: A Guide for Physician Assistants, Surgeons, and District Hospital Traumatologists. 2nd ed. Yaroslavl; Rybinsk: Ryb. Dom Pechati, 2004. 787 p.

  20. Rodseth R.N., Biccard B.M., Le Manach Y. et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J. Am. Coll. Cardiol. 2014; 63: 170–180.

  21. Zhang L.J., Li N., Li Y. et al. Cardiac biomarkers predicting MACE in patients undergoing noncardiac surgery: a meta-analysis. Front. Physiol. 2019; 9: 1923.

  22. Pencle F.J., Varacallo M. Proximal humerus fracture. 2023 Aug 4. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing, 2023. URL: https: //pubmed.ncbi.nlm.nih.gov/ 29262220.

  23. Expert Panel on Musculoskeletal Imaging: Amini B., Beckmann N.M., Beaman F.D. et al. ACR Appropriateness Criteria® Shoulder Pain-Traumatic. J Am Coll Radiol. 2018; 15 (5S): S171-S188.

  24. Wendt K.W., Jaeger M., Verbruggen J. et al. ESTES recommendations on proximal humerus fractures in the elderly. Eur. J. Trauma Emerg. Surg. 2021; 47 (2): 381-395.

  25. Hsu J.R., Mir H., Wally M.K. et al.; Orthopaedic Trauma Association Musculoskeletal Pain Task Force.  Clinical practice guidelines for pain management in acute musculoskeletal injury. J Orthop Trauma. 2019; 33 (5): e158- e182.

  26. Jeger R.V., Probst C., Arsenic R. et al. Long-term prognostic value of the pre-operative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am. Heart J. 2006; 151: 508–513.

  27. Rinfret S., Goldman L., Polanczyk C.A. et al. Value of immediate postoperative electrocardiogram to update risk stratification after major noncardiac surgery. Am. J. Cardiol. 2004; 94: 1017-1022.

  28. Bottiger B.W., Motsch J., Teschendorf P. et al. Postoperative 12-lead ECG predicts peri-operative myocardial ischaemia associated with myocardial cell damage. Anaesthesia. 2004; 59: 1083-1090.

  29. Chang H.Y., Chang W.T., Liu Y.W. Application of transthoracic echocardiography in patients receiving intermediate- or high-risk noncardiac surgery. PLoS ONE. 2019; 14 (4): e0215854

  30. Sougawa H., Ino Y., Kitabata H. et al. Impact of left ventricular ejection fraction and preoperative hemoglobin level on perioperative adverse cardiovascular events in noncardiac surgery. Heart Vessels. 2021; 36: 1317–1326.

  31. Trauma / Ed. by David V. Feliciano, Kenneth L. Mattox, Ernest E. Moore; trans. from English ed. by L.A. Yakimov, N.L. Matveev. Moscow: Panfilov Publishing House; BINOM, 2013.

  32. Bell J.E., Leung B.C., Spratt K.F. et al. Trends and variation in incidence, surgical treatment, and repeat surgery of proximal humeral fractures in the elderly. J. Bone Joint Surg. Amer. 2011; 93 (2): 121-131.

  33. Doleman B., Mathiesen O., Sutton A.J. et al. Non-opioid analgesics for the prevention of chronic postsurgical pain: a systematic review and network meta-analysis. Br. J. Anaesth. 2023; 130(6):719-728.

  34. Golladay G.J., Balch K.R., Dalury D.F. et al. Oral multimodal analgesia for total joint arthroplasty. J. Arthroplasty. 2017; 32 (9, Suppl.): S69-S73.

  35. Wick EC, Grant MC, Wu CL. Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques: a review. JAMA Surg. 2017; 152: 691–697.

  36. Lee SK, Lee JW, Choy WS. Is multimodal analgesia as effective as postoperative patient-controlled analgesia following upper extremity surgery? Orthop. Traumatol. Surg. Res. 2013; 99 (8): 895-901.

  37. Jildeh T.R., Khalil L.S., Abbas M.J. et al. Multimodal nonopioid pain protocol provides equivalent pain control versus opioids following arthroscopic shoulder labral surgery: a prospective randomized controlled trial. J. Shoulder Elbow Surg. 2021; 30 (11): 2445-2454.

  38. Schechter W. Pharmacologic management of acute perioperative pain in infants and children. In: UpToDate, Sun LS (Ed), Wolters Kluwer. (Accessed on March 27, 2024).

  39. Waldron N., Jones C., Gan T. et al. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth. 2012; 110: 191–200.

  40. Hauer J. Pain in children: Approach to pain assessment and overview of management principles. In: UpToDate, Poplack DG (Ed), Wolters Kluwer. (Accessed on April 04, 2024).

  41. Richman J.M., Liu S.S., Courpas G. et al. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth. Analg. 2006; 102 (1): 248-257.

  42. Dattani R, Smith CD, Patel VR. The venous thromboembolic complications of shoulder and elbow surgery: a systematic review. Bone Joint J. 2013; 95-B (1):70-4.

  43. Anakwe R.E., Middleton S.D., Beresford-Cleary N. et al. Preventing venous thromboembolism in elective upper limb surgery. J. Shoul. Elbow Surg. 2013; 22(3): 432–438.

  44. Bozhkova S.A., Tikhilov R.M., Andriyashkin V.V. et al. Prevention, diagnosis, and treatment of thromboembolic complications in traumatology and orthopedics: guidelines. Traumatol. Orthop. Russia. 2022; 28 (3): 136-166.

  45. Seliverstov E.I., Lobastov K.V., Ilyukhin E.A. et al. Prevention, diagnosis and treatment of deep vein thrombosis. Guidelines of Russian experts. Phlebology. 2023; 17 (3): 152-296.

  46. Gillespie W.J., Walenkamp G.H. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev. 2010; 2010(3): CD000244.

  47. Global guidelines for the prevention of surgical site infection, 2-nd ed. Geneva: World Health Organization; 2018. 184 p. – https://www.who.int/publications/i/item/9789241550475

  48. Bratzler D.W., Dellinger E.P., Olsen K.M. et al.; American Society of Health-System Pharmacists (ASHP); Infectious Diseases Society of America (IDSA); Surgical Infection Society (SIS); Society for Healthcare Epidemiology of America (SHEA). Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013; 14 (1): 73-156.

  49. Chang Y., Kennedy S.A., Bhandari M. et al. Effects of antibiotic prophylaxis in patients with open fracture of the extremities: a systematic review of randomized controlled trials. JBJS Rev. 2015; 3 (6): e2.

  50. Sorger J.I., Kirk P.G., Ruhnke C.J. et al. Once daily, high dose versus divided, low dose gentamicin for open fractures. Clin Orthop Relat Res. 1999; (366): 197-204.

  51. Hoff W.S., Bonadies J.A., Cachecho R., Dorlac W.C. East Practice Management Guidelines Work Group: update to practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma. 2011; 70 (3): 751-754.

  52. Takahara S., Tokura T., Nishida R. et al. Ampicillin/sulbactam versus cefazolin plus aminoglycosides for antimicrobial prophylaxis in management of Gustilo type IIIA open fractures: A retrospective cohort study. Injury. 2022; 53 (4): 1517-1522.

  53. Trauma – ICM Philly [Electronic resource]. Metsemakers W.-J., Zalavras C. What is the most optimal prophylactic antibiotic coverage and treatment duration for open fractures of long bones? URL: https://icmphilly.com/questions/what-is-the-most-optimal-prophylactic-antibiotic-coverage-and-treatment-duration-for-open-fractures-of-long-bones. (accessed: 01.08.2023).

  54. Kirsch J.M., Bedi A., Horner N. et al. Tranexamic acid in shoulder arthroplasty: a systematic review and meta-analysis. JBJS Rev. 2017; 5(9): e3.

  55. Cuff D.J., Simon P., Gorman R.A. Randomized prospective evaluation of the use of tranexamic acid and effects on blood loss for proximal humeral fracture surgery. J. Shoulder Elbow Surg. 2020; 29 (8): 1627-1632.

  56. Gibbs V.N., Geneen L.J., Champaneria R. et al. Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures. Cochrane Database Syst Rev. 2023; 6 (6): CD013499.

  57. Shin H.W., Park J.J., Kim H.J. et al. Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: A systematic review and meta-analysis. PLoS One. 2019; 14(5): e0215427.

  58. Jones J.J., Mundy L.M., Blackman N., Shwarz M. Ferric carboxymaltose for anemic perioperative populations: a systematic literature review of randomized controlled trials. J. Blood Med. 2021; 12: 337-359.

  59. Kancherla V.K., Singh A., Anakwenze O.A. Management of acute proximal humeral fractures. J. Amer. Acad. Orthop. Surg. 2017; 25 (1): 42-52.

  60. Sears B.W., Johnston P.S., Garrigues G.E. et al. Intramedullary nailing of the proximal humerus – not just for 2-part fractures. Ann. Joint. 2020; 5: 32.

  61. Magovern B., Ramsey M.L. Percutaneous fixation of proximal humerus fractures. Orthop. Clin. North. Amer. 2008; 39(4): 405-416.

  62. Dilisio M.F., Nowinski R.J., Hatzidakis A.M., Fehringer E.V. Intramedullary nailing of the proximal humerus: evolution, technique, and results. J. Shoulder Elbow Surg. 2016; 25 (5): e130-8.

  63. Nowak L.L., Dehghan N., McKee M.D., Schemitsch E.H. Plate fixation for management of humerus fractures. Injury. 2018; 49: S33-S38.

  64. Freeman T.R., Dunn R.H., Ko K.J.W., Seidl A.J. Hemiarthroplasty for proximal humerus fracture – a dying art. Ann. Joint. 2021; 6: 15.

  65. Neer C.S. Displaced proximal humeral fractures. Part II. Treatment of three-part and four-part displacement. J. Bone Joint Surg. Amer. 1970; 52: 1090-1103.

  66. Boileau P., Walch G., Krishnan S.G. Tuberosity osteosynthesis and hemiarthroplasty for four-part fractures of the proximal humerus. Techniques in shoulder and elbow surgery. 2000; 1: 96-109.

  67. Mighell M.A., Kolm G.P., Collinge C.A. et al. Outcomes of hemiarthroplasty for fractures of the proximal humerus. J. Shoulder Elbow Surg. 2003; 12: 569-577.

  68. Boons H.W., Goosen J.H., van Grinsven S. et al. Hemiarthroplasty for humeral four-part fractures for patients 65 years and older: A randomized controlled trial. Clin. Orthop. Relat. Res. 2012; 470: 3483-3491.

  69. Lee B.K., Itamura J.M. Reverse shoulder arthroplasty for proximal humerus fractures. Ann. Joint. 2021; 6: 24.

  70. Namdari S., Horneff J.G., Baldwin K. Comparison of hemiarthroplasty and reverse arthroplasty for treatment of proximal humeral fractures: A systematic review. J Bone Joint Surg. Amer. 2013; 95 (18): 1701-1708.

  71. Sebastiá-Forcada E., Cebrián-Gómez R., Lizaur-Utrilla A., Gil-Guillén V. Reverse shoulder arthroplasty versus hemiarthroplasty for acute proximal humeral fractures: A blinded, randomized, controlled, prospective study. J Shoulder Elbow Surg. 2014; 23(10): 1419-1426.

  72. Anakwenze O.A., Zoller S., Ahmad C.S., Levine W.N. Reverse shoulder arthroplasty for acute proximal humerus fractures: A systematic review. J Shoulder Elbow Surg. 2014; 23 (4): e73-e80.

  73. Ferrel J.R., Trinh T.Q., Fischer R.A. Reverse total shoulder arthroplasty versus hemiarthroplasty for proximal humeral fractures: A systematic review. J. Orthop. Trauma 2015; 29 (1): 60-68.

  74. Prevention of Surgical Site Infections. Guidelines / National Association of Healthcare-Associated Infection Control Specialists (NASCI). Moscow, 2022. 74 p.

  75. Pashikanti L., Von Ah D. Impact of early mobilization protocol on the medical- surgical inpatient population: an integrated review of literature. Clin. Nurse Spec. 2012; 26 (2): 87-94.

  76. Traumatology and Orthopedics / Ed. by N.V. Kornilov, A.K. Dulaev. Moscow, GEOTAR-Media, 2020. 655 p.

  77. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J. Amer. Geriatr. Soc. 2023; 71 (7): 2052-2081.

  78. Kietaibl S., Ferrandis R., Godier A. et al. Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines. Eur J Anaesthesiol. 2022; 39(2): 100-132.

  79. Jameson S.S., James P., Howcroft D.W. et al. Venous thromboembolic events are rare after shoulder surgery: Analysis of a national database. J. Shoulder Elbow Surg. 2011; 20 (5): 764–770.

  80. Ojike N.I., Bhadra A.K., Giannoudis P.V., Roberts C.S. Venous thromboembolism in shoulder surgery: a systematic review. Acta Orthop. Belgica. 2011; 77 (3): 281–289.

  81. Sager B., Ahn J., Tran J., Khazzam M. Timing and risk factors for venous thromboembolism after rotator cuff repair in the 30-day perioperative period. Arthroscopy. 2019; 35 (11): 3011-3018.

  82. SanPiN 3.3686-21 "Sanitary and epidemiological requirements for the prevention of infectious diseases" (approved by the Decree of the Chief State Sanitary Inspector of the Russian Federation No. 4 dated January 28, 2021) (as amended on May 25, 2022).

  83. Liang J.L., Tiwari T., Moro P. et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018; 67(2): 1–44.

  84. Ratajczak K., Szczęsny G., Małdyk P. Comminuted fractures of the proximal humerus - principles of the diagnosis, treatment and rehabilitation. Ortop. Traumatol. Rehabil. 2019; 21 (2): 77-93.

  85. Kancherla V.K., Singh A., Anakwenze O.A. Management of acute proximal humeral fractures. J. Amer. Acad. Orthop. Surg. 2017; 25 (1): 42-52.

  86. Ribinik P., Calmels P., Edouard P. et al. Care pathways in physical and rehabilitation medicine (PRM): the patient after proximal humeral fracture and shoulder hemi-arthroplasty. Ann Phys Rehabil Med. 2012; 55 (8): 557-64.

  87. Vachtsevanos L., Hayden L., Desai A.S., Dramis A. Management of proximal humerus fractures in adults. World J Orthop. 2014; 5(5): 685-693.

  88. Hodgson S. Proximal humerus fracture rehabilitation. Clin Orthop Relat Res. 2006; 442: 131-138.

  89. Herteleer M., Runer A., Remppis M. et al. Continuous shoulder activity tracking after open reduction and internal fixation of proximal humerus fractures. Bioengineering (Basel). 2023; 10(2): 128.

  90. Kennedy J.S., Garrigues G.E., Pozzi F. at al. The American Society of Shoulder and Elbow Therapists' consensus statement on rehabilitation for anatomic total shoulder arthroplasty. J Shoulder Elbow Surg. 2020; 29 (10): 2149-2162.

  91. Howard M.C., Trasolini N.A., Waterman B.R. Optimizing outcomes after reverse total shoulder arthroplasty: rehabilitation, expected outcomes, and maximizing return to activities. Curr. Rev. Musculoskeletal Med. 2023; 16: 145–153.

  92. Bullock GS, Garrigues GE, Ledbetter L, Kennedy J. A systematic review of proposed rehabilitation guidelines following anatomic and reverse shoulder arthroplasty. J Orthop Sports Phys Ther. 2019; 49(5): 337-346.

  93. Lee J., Consigliere P., Fawzy E. et al. Accelerated rehabilitation following reverse total shoulder arthroplasty. J Shoulder Elbow Surg. 2021; 30(9): e545-e557.

  94. Brindisino F., Lorusso M., Usai M. et al. Rehabilitation following shoulder arthroplasty: a survey of current clinical practice patterns of Italian physiotherapists. Arch Physiother 2023; 13: 12.

  95. Salamh P.A., Speer K.P. Post-rehabilitation exercise considerations following total shoulder arthroplasty. Strength Conditioning J. 2013. 35(4): 56-63.

  96. Khalil L.S., Abbas M.J., Rahman T.M. et al. The effect of subscapularis-specific rehabilitation following total shoulder arthroplasty: a prospective, double-blinded, randomized controlled trial. J Shoulder Elbow Surg. 2023; 32 (9): 1857-1866.

  97. Liu J.N., Steinhaus M.E., Garcia G.H., et al. Return to sport after shoulder arthroplasty: a systematic review and meta‑analysis.  Knee Surg Sports Traumatol Arthrosc. 2018; 26(1): 100-112.

  98. MacIntyre N.J., Kwan L.L., Johal H. et al. Rehabilitation of proximal humerus fractures- a scoping review. SM J Trauma Care. 2017; 1(1): 1001.

  99. Budharaju A., Hones M., Hao A. et al. Rehabilitation protocols in proximal humerus fracture management: A systematic review. Shoulder & Elbow. 2023; doi: 10.1177/17585732231182374.

  100. Martinez-Catalan N. Conservative treatment of proximal humerus fractures: when, how, and what to expect. Curr Rev Musculoskelet Med. 2023; 16(2): 75-84.

  101. Hudak P.L. Amadio P.C., Bombardier C. Development of an upper extremity outcome measure: the DASH (Disabilities of the Arm, Shoulder, and Hand)." Amer. J. Industr. Med. 1996: 29 (6): 602-608.

  102. Wajngarten D., Campos J.Á.D.B., Garcia P.P.N.S. The Disabilities of the Arm, Shoulder and Hand scale in the evaluation of disability - A literature review. Med Lav. 2017; 108 (4): 314-323.

  103. Beaton D.E., Wright J.G., Katz J.N; Upper Extremity Collaborative Group. Development of the DASH: comparison of three item-reduction approaches. J Bone Joint Surg Am. 2005; 87 (5): 1038-1046;

  104. Gummesson C., Ward M.M., Atroshi I. The shortened disabilities of the arm, shoulder and hand questionnaire (Quick DASH): validity and reliability based on responses within the full-length DASH. BMC musculoskeletal disorders. 2006; 7: 44.

  105. Franchignoni F., Vercelli S., Giordano A et al. Minimal clinically important difference of the disabilities of the arm, shoulder and hand outcome measure (DASH) and its shortened version (QuickDASH). J Orthop Sports Phys Ther. 2014; 44 (1): 30-9.

  106. Tsang P., Walton D., Grewal R., MacDermid J. Validation of the QuickDASH and DASH in patients with distal radius fractures through agreement analysis. Arch Phys Med Rehabil. 2017; 98 (6): 1217-1222.e1.

  107. Aasheim T., Finsen V. The DASH and the QuickDASH instruments. Normative values in the general population in Norway. J Hand Surg Eur Vol. 2014; 39(2): 140-4.

  108. Macdermid J.C., Khadilkar L., Birmingham T.B., Athwal G.S. Validity of the QuickDASH in patients with shoulder-related disorders undergoing surgery. J Orthop Sports Phys Ther. 2015; 45 (1): 25-36.

  109. Fayad F., Lefevre-Colau M.M., Gautheron V.  et al. Reliability, validity and responsiveness of the French version of the questionnaire Quick Disability of the Arm, Shoulder and Hand in shoulder disorders. Man Ther. 2009; 14 (2): 206-12.

  110. [1] Galardini L., Coppari A., Pellicciari L. et al. Minimal clinically important difference of the Disabilities of the Arm, Shoulder and Hand (DASH) and the shortened version of the DASH (QuickDASH) in people with musculoskeletal disorders: a systematic review and meta-analysis. Phys Ther. 2024 Mar 4: pzae033.

  111. Abbot S., Proudman S., Sim Y.P, Williams N. Psychometric properties of patient-reported outcomes measures used to assess upper limb pathology: a systematic review. ANZ J Surg. 2022; 92 (12): 3170-3175.

  112. Heyworth B., Cohen L., von Heideken J. et al. Validity and comprehensibility of outcome measures in children with shoulder and elbow disorders: creation of a new Pediatric and Adolescent Shoulder and Elbow Survey (Pedi-ASES). J Shoulder Elbow Surg. 2018; 27 (7): 1162-1171.

  113. Quatman-Yates C.C., Gupta R., Paterno M.V. et al. Internal consistency and validity of the QuickDASH instrument for upper extremity injuries in older children. J Pediatr Orthop. 2013; 33 (8): 838-842. 

  114. Goldman L., Caldera D.L., Nussbaum S.R. et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977; 297 (16): 845-850.

  115. Lee T.H., Marcantonio E.R., Mangione C.M. et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100 (10): 1043-9.

  116. Davis C., Tait G., Carroll J. et al. The Revised Cardiac Risk Index in the new millennium: a single-centre prospective cohort re-evaluation of the original variables in 9,519 consecutive elective surgical patients. Can. J. Anaesth. 2013; 60 (9): 855-863.

  117. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008; 133(6 Suppl): 381s-453s.

  118.  Meier K.A., Clark E., Tarango C. Et al. Venous thromboembolism in hospitalized adolescents: an approach to risk assessment and prophylaxis. Hosp. Pediatrics. 2015; 5(1): 44-51.

  119. Newall F., Branchford B., Male C. Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. J. Thrombosis Haemostasis. 2018; 16 (2): 196-208.

  120. Mahajerin A., Webber E.C., Morris J. et al. Development and implementation results of a venous thromboembolism prophylaxis guideline in a tertiary care pediatric hospital. Hosp. Pediatrics. 2015; 5(12): 630-636.

  121. Odent T., de Courtivron B., Gruel Y. Thrombotic risk in children undergoing orthopedic surgery. Orthop Traumatol Surg Res. 2020; 106 (1S): S109-S114.

  122. Mills K., Hill C., King M. et al. Just DOAC: Use of direct-acting oral anticoagulants in pediatrics. Am J Health Syst Pharm. 2023; 80 (7): 412-422.

  123. Cheng Y. Venous thromboembolism prophylaxis. Pediatric. Inpatient Clinical Practice Guideline. University of Wisconsin Hospitals and Clinics Authority, 2023. 14 p. URL: https: //www.uwhealth.org/cckm/cpg/hematology-and-coagulation/Pediatric-VTE-PPX-Consensus-Care-GL---April-2023-Final.pdf

  124. Giossi R., Menichelli D., D'Amico F. et al. Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis. J. Thromb. Haemost. 2023; 21 (10): 2784-2796.

  125. Trame M.N., Mitchell L., Krumpel A. et al. Population pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study. J. Thrombosis Haemostasis. 2010; 8(9): 1950-1958.

  126. Lyle C.A., Sidonio R.F., Goldenberg N.A. New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants. Curr. Opinion Pediatr. 2015; 27 (1): 18-25.

  127. Raffini L., Trimarchi T., Beliveau .J, Davis D. Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative. Pediatrics. 2011; 127(5): e1326-1332.

  128. Dix D., Andrew M., Marzinotto V. et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J. Pediatr. 2000;136(4):439-445.

  129. Kennedy A.P., Ignacio R.C., Ricca R. (eds.) Pediatric Trauma Care. A Practical Guide. Springer, 2022: 572 p.

  130. Marzi I., Frank J., Rose S. Pediatric Skeletal Trauma. A Practical Guide. Berlin: Springer, 2022: 626 p.

  131. Tang P., Chen H. (eds.) Orthopaedic trauma surgery. Volume 1: Upper extremity fractures and dislocations. Springer Singapore, 2023. 302 p.

  132. Bairov G.A., Gorenstein A.I., Baindurashvili A.G. et al. Pediatric Traumatology. – 2nd ed. – St. Petersburg: Piter, 2000. – 384 p.

  133. Drendel AL, Lyon R, Bergholte J, Kim MK. Outpatient pediatric pain management practices for fractures. Pediatr Emerg Care. 2006; 22 (2): 94-9.

  134.          Orliaguet G., Hamza J., Couloigner V. et al. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol. Pediatrics. 2015; 135 (3): e753-5.

  135. Vlasova A.V., Smirnova E.V., Tenovskaya T.A. et al. Protocol for perioperative and post-exposure antibiotic prophylaxis at the Morozov City Children's Clinical Hospital of the Moscow Healthcare Department. Metropolitan Health. 2021; 2 (2): 46-64.

  136. Opri F., Bianchini S., Nicoletti L. et al. on behalf of the Peri-Operative Prophylaxis in Neonatal and Paediatric Age (POP-NeoPed) Study Group. Surgical antimicrobial prophylaxis in patients of neonatal and pediatric age undergoing orthopedic and hand surgery: A RAND /UCLA Appropriateness Method Consensus Study. Antibiotics. 2022; 11: 289.

  137. Wei Y., Zhang Y., Jin T. et al. Effects of tranexamic acid on bleeding in pediatric surgeries: a systematic review and meta-analysis. Front Surg. 2021; 8: 759937.

  138. National Institute for Health and Care Excellence. Blood transfusion: NICE guideline (NG24), 2015. URL: https://www.nice.org.uk/guidance/ng24/resources/blood-transfusion-pdf-1837331897029

  139. Bernière J., Dehullu J.P., Gall O., Murat I. Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents. Rev. Chir. Orthop. Reparatrice Appar. Mot. 1998; 84: 319–322.

  140. Charuvila S, Davidson SE, Thachil J, Lakhoo K. Surgical decision making around paediatric preoperative anaemia in low-income and middle-income countries. Lancet Child Adolesc. Health. 2019; 3 (11): 814-821

  141. Gao J., Yu X., Cao G. et al. Assessing the impact of the 2018 tetanus guidelines on knowledge and practices of emergency physicians in trauma patients: a national survey study. Peer J. 2023: 11: e16032

Appendix A1. Working Group Composition

  1. Belenky I.G., MD, Associate Professor, Saint Petersburg I.I. Джанелидзе Research Institute of Emergency Medicine, St. Petersburg, member of ATOR.

  2. Bozhkova S.A., MD, Vreden National Medical Research Center of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation, St. Petersburg, member of ATOR

  3. Geroeva I.B., MD, Professor, Priorov National Medical Research Center of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation, Moscow.

  4. Kleymenova E.B., MD, Professor, Priorov National Medical Research Center of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation, Moscow.

  5. Mayorov B.A., PhD, Saint Petersburg I.I. Dzhanelidze Research Institute of Emergency Medicine, Pavlov First Saint Petersburg State Medical University, St. Petersburg, member of ATOR.

  6. Nazarenko A.G., MD, Professor of the RAS, Director of the Priorov National Medical Research Center of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation, Moscow, Vice President of ATOR.

  7. Otdelenov V.A., PhD, Priorov National Medical Research Center of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation, Moscow.

  8. Proshchenko Ya.N., MD, Turner National Medical Research Center for Children's Orthopedics and Trauma of the Russian Ministry of Health, St. Petersburg.

  9. Sergeev G.D., PhD, Saint Petersburg I.I. Dzhanelidze Research Institute of Emergency Medicine, St. Petersburg, member of ATOR.

Conflict of interest.

The working group for drafting clinical guidelines for the treatment of proximal humeral fractures has no conflicts of interest.

Appendix A2. Methodology for Developing Clinical Guidelines

Target audience for these clinical guidelines:

1. Orthopedic trauma surgeons

2. Surgeons

3. General practitioners

4. Medical rehabilitation physicians

5. Healthcare organization and public health specialists.

Stages of evaluating the levels of evidence and grades of recommendation:

1. Definition of search criteria and selection of publications on clinical trials (CTs) regarding the efficacy and/or safety of the medical intervention described in the recommendation statement.

2. Systematic search and selection of CT publications in accordance with the previously established criteria.

Systematic search and selection of clinical trial publications:

The evidence base for the recommendations consisted of publications retrieved via information retrieval in the following databases: Central Scientific Medical Library (CSML) "Russian Medicine", MEDLINE (US NLM), and COCHRANE Library; scientific electronic libraries eLibrary.ru and "CyberLeninka"; as well as on the Internet using Yandex, Google, and Google Scholar search engines, by reviewing leading specialized peer-reviewed domestic medical journals on the subject and treatment guidelines for fractures from the international Association for Osteosynthesis AO/ASIF.

Table 1. Levels of Evidence (LoE) grading scale for diagnostic methods (diagnostic interventions)

LoE

Definition

1

Systematic reviews of studies with reference standard control or systematic reviews of randomized controlled trials with meta-analysis

2

Individual studies with reference standard control or individual randomized controlled trials and systematic reviews of studies of any design, except randomized controlled trials, with meta-analysis

3

Studies without consecutive reference standard control or studies with a reference standard not independent of the test method, or non-randomized comparative studies, including cohort studies

4

Non-comparative studies, case report

5

Only justification of mechanism of action or expert opinion is available

Table 2. Scale for grading levels of evidence certainty (LEC) for prevention, treatment, and rehabilitation methods (preventive, therapeutic, and rehabilitative interventions)

LoE

Definition

1

Systematic review of RCTs with meta-analysis

2

Individual RCTs and systematic reviews of studies of any design except RCTs, with meta-analysis

3

Non-randomized comparative studies, including cohort studies

4

Non-comparative studies, case reports or case series, case-control studies

5

Only justification of the mechanism of action of the intervention (preclinical studies) or expert opinion is available

Table 3. Scale for grading grades of recommendation (GR) for prevention, diagnostic, treatment, and rehabilitation methods (preventive, diagnostic, therapeutic, and rehabilitative interventions)

GoR

Definition

A

Strong recommendation (all considered efficacy criteria (outcomes) are important, all studies are of high or acceptable methodological quality, and their conclusions on the outcomes of interest are consistent)

B

Conditional recommendation (not all considered efficacy criteria (outcomes) are important, not all studies are of high or acceptable methodological quality, and/or their conclusions on the outcomes of interest are inconsistent)

C

Weak recommendation (lack of adequate quality evidence (all considered efficacy criteria (outcomes) are unimportant, all studies are of low methodological quality, and their conclusions on the outcomes of interest are inconsistent)

Procedure for updating clinical guidelines.

The mechanism for updating clinical guidelines provides for their systematic revision at least once every three years, as well as upon the emergence of new evidence-based medicine data on the diagnosis, treatment, prevention, and rehabilitation of specific diseases, or in the presence of justified additions/comments to previously approved clinical guidelines, but no more frequently than once every 6 months.

Appendix A3. Reference Materials

Appendix A3.1 Pain management recommendations for major musculoskeletal trauma (surgical fixation of long bone fractures or complex joint fractures, extensive soft tissue trauma, extensive surgery, etc.) in adults

The table presents analgesic medications and their dosage regimens in accordance with the clinical guidelines for pain management in acute musculoskeletal trauma [25].

Stage of treatment

Opioid analgesics

from group N02A

Non-opioid analgesics and gabapentin

Inpatient setting

Trimeperidine** 25–50 mg orally. Maximum single dose is 50 mg, maximum daily dose is 200 mg.

Ketorolac** 15 mg IV every 6 hours x 5 doses, then #ibuprofen** 600 mg orally every 8 hours [25]

OR Trimeperidine** 10–40 mg (from 1 ml of 10 mg/ml solution to 2 ml of 20 mg/ml solution) IM, SC, or IV. Maximum single dose is 40 mg, daily dose is 160 mg.

Gabapentin 300 mg 3 times daily

Morphine** 10–30 mg IM or SC as needed for severe breakthrough pain

Paracetamol** 500 mg orally every 12 hours

Outpatient stage

First week (after discharge)

Tramadol** single dose 100 mg orally as needed; if analgesia is insufficient, repeat 100 mg after 30–60 minutes. Maximum daily dose is 400 mg.

#Ibuprofen** 600 mg orally every 8 hours for 7 days [25]

#Gabapentin 100 mg 1 tablet orally 3 times daily for 7 days [25]

Paracetamol** 500 mg orally every 12 hours for 7 days

Second week

Tramadol** single dose 50 mg orally as needed; if analgesia is insufficient, repeat 50 mg after 30–60 minutes. Maximum daily dose is 400 mg.

NSAIDs as needed

Gabapentin 300 mg 3 times daily (if necessary, gradually increase to the maximum daily dose: 3600 mg/day) [25]

Paracetamol** 500 mg orally every 12 hours (dose may be increased as opioid doses are tapered)

Third week

Tramadol** single dose 50 mg orally as needed; if analgesia is insufficient, repeat 50 mg after 30–60 minutes. Maximum daily dose is 400 mg.

NSAIDs as needed

Gabapentin as needed (max. 3600 mg/day)

Paracetamol** 1000 mg orally every 12 hours (dose may be increased as opioid doses are tapered)

Fourth week

Tramadol** single dose 50 mg orally as needed; if analgesia is insufficient, repeat 50 mg after 30–60 minutes. Maximum daily dose is 400 mg.

NSAIDs as needed

Gabapentin as needed (max. 3600 mg/day)

Paracetamol** 1000 mg orally every 8 hours (dose may be increased as opioid doses are tapered)

Fifth week and beyond

-

NSAIDs as needed

Paracetamol** as needed

Gabapentin as needed, then discontinue.

Appendix A3.2 Pain management recommendations for non-surgical musculoskeletal trauma (closed fractures, superficial wounds, etc.) in adults

Type of injury

Opioid analgesics

Non-opioid analgesics

Minor trauma (minor bone fractures, sprains, superficial wounds)

Tramadol** single dose 50 mg orally as needed; if analgesia is insufficient, repeat 50 mg after 30–60 minutes. Maximum daily dose is 400 mg.

NSAIDs as needed,

paracetamol** 1000 mg orally every 8 hours, then as needed

OR tramadol** single dose 50 mg IV as needed; if analgesia is insufficient, repeat 50 mg after 30–60 minutes. Maximum daily dose is 400 mg.

Major trauma (major bone fractures, ruptures)

Tramadol** single dose 50 mg orally as needed; if analgesia is insufficient, repeat 50 mg after 30–60 minutes. Maximum daily dose is 400 mg.

NSAIDs as needed,

paracetamol** 1000 mg orally every 12 hours, then as needed

OR Tramadol** single dose 50 mg IV on demand; if pain control is inadequate, repeat 50 mg in 30–60 minutes. Maximum daily dose 400 mg

Appendix A3.3. Recommendations for Postoperative Analgesia in Children

Medicinal products

Single dose

Dosing regimen

Maximum daily dose

Maximum duration of use

Non-narcotic analgesic

Paracetamol**

Rectal suppositories:

3-6 months (6-8 kg): 50 mg

rectally at intervals of at least 4-6 hours

100 mg/day

Not specified in the instructions

7-12 months (8-11 kg): 100 mg

200 mg/day

1-4 years (12-16 kg): 100 mg

400 mg/day

5-9 years (17-30 kg): 250 mg

1000 mg/day

10-14 years: 500 mg

2000 mg/day

over 15 years: 500 mg

4000 mg/day

IV infusion:

10 kg and under: 7.5 mg/kg (0.75 ml/kg)

no more than 4 times/day, interval between infusions at least 4 hours

no more than 30 mg/kg/day

Not specified in the instructions

from 10 kg up to 33 kg inclusive: 15 mg/kg (1.5 ml/kg)

less than 60 mg/kg inclusive, but not more than 2 g

from 33 to 50 kg inclusive: 15 mg/kg (1.5 ml/kg)

less than 60 mg/kg inclusive, but not more than 3 g

over 50 kg: 1 g (100 ml)

no more than 4 g/day

Tablets

3-5 years: 200 mg

Every 4-6 hours

no more than 4 times a day

6-8 years: 250 mg

no more than 4 times a day

9-11 years: 500 mg

no more than 4 times a day

Over 12 years: 500-1000 mg

no more than 4 g/day

Nonsteroidal anti-inflammatory drugs

Diclofenac**

Powder for oral solution

14-18 years: 50-100 mg

0.5-2 mg/kg per day orally, daily dose divided into 2-3 single doses

150 mg

7 days

Tablets:

6-14 years: 25 mg

0.5-2 mg/kg per day orally, daily dose divided into 2-3 single doses

150 mg

7 days

14-18 years: 25-50 mg

Ibuprofen**

Suspension (100 mg/5 ml):

3-6 months (5-7.6 kg): 2.5 ml (50 mg)

orally up to 3 times/day at intervals of 6-8 hours

7.5 ml (150 mg)

Not specified in the instructions

6-12 months (7.7-9 kg): 2.5 ml (50 mg)

orally 3-4 times/day at intervals of 6-8 hours

10 ml (200 mg)

1-3 years (10-16 kg): 5 ml

orally up to 3 times/day at intervals of 6-8 hours

15 ml (300 mg)

4–6 years (17–20 kg): 7.5 ml

22.5 ml (450 mg)

7–9 years (21–30 kg): 10 ml

30 ml (600 mg)

10–12 years (31–40 kg): 15 ml

45 ml (900 mg)

Suspension (200 mg / 5 ml):

1–3 years (10–16 kg): 2.5 ml (100 mg)

orally up to 3 times/day at intervals of 6-8 hours

7.5 ml (300 mg)

Not specified in the instructions

4–6 years (17–20 kg): 3.75 ml (150 mg)

11.25 ml (450 mg)

7–9 years (21–30 kg): 5 ml (200 mg)

15 ml (600 mg)

10–12 years (31–40 kg): 7.5 ml (300 mg)

22.5 ml (900 mg)

over 12 years (over 40 kg): 7.5–10 ml (300–400 mg)

30 ml (1200 mg)

Tablets:

aged 6 to 12 years (body weight > 20 kg): 200 mg

orally up to 4 times/day with an interval of at least 6 hours

800 mg

Not specified in the instructions

children over 12 years: 200 mg

orally 3–4 times/day with an interval of at least 6 hours

rectal suppositories, [FOR CHILDREN]

3–9 months (6.0 kg – 8.0 kg): 1 suppository (60 mg)

Up to 3 times per 24 hours, maximum 180 mg per day

30 mg/kg with dosing intervals of 6–8 hours

Maximum 3 days

9 months – 2 years (8.0 kg – 12.0 kg): 1 suppository (60 mg)

Up to 4 times per 24 hours, maximum 240 mg per day

Ketorolac**

Tablets:

children over 16 years: 10 mg

orally up to 4 times/day

40 mg

5 days

Parenteral solution

over 16 years: 10–30 mg

IV, IM with an interval of at least 6 hours

90 mg

2 days

Opioid and opioid-like analgesics

Morphine**

Oral solution/tablets

3 to 7 years: 5 mg

orally, every 6 hours

20 mg

Not specified in the instructions

7 to 17 years with body weight up to 70 kg: 5 mg

orally,

every 4 hours

30 mg

7 to 17 years with body weight of 70 kg or more: 10 mg

60 mg

17 years and older: 5–10 mg

Not specified in the instructions

Parenteral solution:

birth to 2 years: 100–200 mcg/kg body weight (0.1–0.2 mg/kg)

SC, if necessary every 4–6 hours.

15 mg

Not specified in the instructions

over 2 years: 100–200 mcg/kg body weight (0.1–0.2 mg/kg)

SC if necessary every 4–6 hours

Tramadol**1

Parenteral solution

1 to 12 years*: 1–2 mg/kg

IV, IM, SC

8 mg/kg/day or maximum 400 mg/day

from 12 years: 50–100 mg

IV, IM, SC; if satisfactory analgesia is not achieved 30–60 minutes after the initial dose, an additional 50 mg may be administered

400 mg/day

Not specified in the instructions

Tablets:

children over 14 years of age:

50–100 mg

orally; if satisfactory analgesia is not achieved within 30–60 minutes after the initial administration, an additional 50 mg may be prescribed

400 mg/day

Not specified in the instructions

Trimeperidine**

Parenteral solution

Children2 over 2 years of age: 3–10 mg

IV, IM, SC

Not specified in the instructions

Not specified in the instructions

Fentanyl**

Parenteral solution

children from 1 year of age with spontaneous breathing: initial dose 3–5 mcg/kg, additional dose 1 mcg/kg.

IV

Not specified in the instructions

Not specified in the instructions

children from 1 year of age receiving mechanical ventilation: initial dose 15 mcg/kg, additional dose 1–3 mcg/kg.

IV

Not specified in the instructions

Not specified in the instructions

1 In children under 12 years of age, morphine** is the preferred agent when opioid analgesics are indicated, as the use of tramadol** is associated with a higher risk of adverse reactions [40, 134].

2 Not recommended for use in children because its metabolite accumulates in the body and provokes seizures upon repeated administration [38].

Appendix A3.4 Recommended dosing regimens of low molecular weight heparins for the prophylaxis of high-risk VTE in conservative treatment and orthopedic surgery in adult patients at high risk for VTE

Drug

Recommended doses, frequency, and route of administration

Sodium heparin**

Subcutaneously, 5,000 IU 3 times daily

For interventions, the first injection is given 1–2 hours before surgery

Bemiparin sodium

Subcutaneously, 3,500 IU anti-Xa once daily

For interventions, 2 hours before surgery or 6 hours after, and every 24 hours on subsequent days

Daltaparin sodium

Choose one of the dosing regimens below.

a. when starting prophylaxis the day before surgery: 5000 IU SC on the evening before surgery, then 5000 IU SC every evening after surgery.

b. when starting prophylaxis on the day of surgery: 2500 IU SC 2 hours before surgery and 2500 IU SC 8–12 hours later, but no earlier than 4 hours after the end of surgery. Then starting the next day, every morning 5000 IU SC.

c. when starting prophylaxis after surgery: 2500 IU SC 4–8 hours after surgery, but no earlier than 4 hours after the end of surgery. Then starting the next day, 5000 IU SC daily.

Nadroparin calcium

Subcutaneously (standard dosage: 9,500 anti-Xa IU/ml):

1. For VTE prophylaxis in patients at high risk of thrombosis:

1) body weight up to 70 kg: 0.4 ml once daily;

2) body weight 70 kg and over: 0.6 ml once daily;

3) for elderly patients, a dose reduction to 0.3 ml is advisable.

2. For orthopedic interventions:

1) Body weight up to 50 kg: 0.2 ml 12 hours before and 12 hours after surgery, then once daily until the 3rd postoperative day; from the 4th postoperative day, 0.3 ml once daily;

2) Body weight 50–69 kg: 0.3 ml 12 hours before and 12 hours after surgery, then once daily until the 3rd postoperative day; from the 4th postoperative day, 0.4 ml once daily.

3) Body weight 70 kg and over: 0.4 ml 12 hours before and 12 hours after surgery, then once daily until the 3rd postoperative day; from the 4th postoperative day, 0.6 ml once daily.

Enoxaparin sodium**

Subcutaneously, 40 mg once daily

For interventions, 12 hours before and 12 hours after surgery, then once daily throughout the postoperative period

Parnaparin sodium**

Subcutaneously, 0.4 ml (4,250 anti-Xa IU) once daily

For interventions, 12 hours before and 12 hours after surgery, then once daily throughout the postoperative period

Appendix A3.5. Bleeding Risk Factors in Children Aged 6 Months to 18 Years

Pharmacoprophylaxis of VTE

NOT RECOMMENDED

(absolute contraindications)

Relative contraindications

to pharmacological VTE prophylaxis

• Intracranial hemorrhage

• Cerebral ischemia / acute stroke

• Active bleeding

• Recent thrombolytic therapy (<24 hours)

• Intracranial mass lesion

• Recent lumbar puncture (<24 hours ago)

• Coagulopathy

• Neurosurgical procedure

• Pelvic fracture within the last 48 hours

• Uncontrolled hypertension

• Recent use of aspirin or antiplatelet agents (<5-7 days ago)

Notes:

1. If the patient meets at least one of the "NOT recommended" criteria, avoid pharmacological prophylaxis, as the risk outweighs the benefit.

2. If the patient has at least one relative contraindication criterion, consider withholding pharmacological prophylaxis.

3. Consider a hematology consultation if the patient is at high VTE risk with a high bleeding risk [119].

4. Uncontrolled hypertension is defined as systolic or diastolic blood pressure above the 95th percentile for age, height, and sex [120].

5. Coagulopathy is defined as INR > 1.5, aPTT > 44 s, fibrinogen < 100 g/L, or platelets < 50,000/µL.

Appendix A3.6. VTE risk factors in children aged 6 months to 18 years [113, 129]

Acute conditions

  • Reduced mobility for more than 72 hours

  • Central venous access device

  • Active infection

  • Severe trauma or burn

  • Major surgery

  • Pregnancy

  • Critically ill

Chronic conditions

  • Autoimmune disorders associated with thrombosis

  • Thrombophilic state

  • Active malignancy

  • Active inflammatory condition

  • Smoking

  • Estrogen therapy

  • Obesity

Anamnestic factors

  • Asparaginase within the previous 30 days

  • Recent surgery within the past 30 days

  • History of thrombosis

  • Family history of VTE in a 1st-degree relative < 40 years of age at the time of thrombosis

Notes:

− Reduced mobility is defined as a decrease in mobility compared to baseline or the inability to participate in physical therapy.

− A central venous access device is defined as a non-tunneled catheter, tunneled catheter, or central venous catheter.

− A major burn is defined as a burn involving more than 50% of the body surface area.

− Major surgical procedures include operations lasting longer than 45 minutes.

− Critically ill patients are defined as those admitted to an intensive care unit (requiring inotropic support or mechanical ventilation).

− Thrombophilic states include antithrombin deficiency, protein C or S deficiency, factor V Leiden, or prothrombin gene mutation.

− Active malignancy is defined as receiving chemotherapy/radiation therapy within the preceding 6 months.

− Active inflammatory disease includes Kawasaki disease, inflammatory bowel disease, systemic lupus erythematosus, or nephrotic syndrome.

− Estrogen therapy includes oral contraceptives, estrogen replacement therapy, or use within the past 2 weeks.

− Obesity is defined as a BMI above the 95th percentile for age.

Key:

Low VTE risk:

• No altered mobility and 0-1 risk factor

Moderate VTE risk:

• No mobility impairment and 2-3 risk factors

• Altered mobility and 0-1 other risk factors

High VTE risk:

• No mobility impairment and ≥4 risk factors

• Altered mobility and ≥2 other risk factors

Thromboprophylaxis recommendation

VTE risk level

Thromboprophylaxis management

Low VTE risk

· Early mobilization

· No prophylaxis needed

Moderate VTE risk

High VTE risk

and high bleeding risk

· Early mobilization

· Mechanical prophylaxis

High VTE risk and low bleeding risk

· Early mobilization

· Mechanical and pharmacological prophylaxis

Appendix B. Physician Action Algorithms

Appendix B1. Algorithm of physician actions in suspected humerus fracture

Appendix B2. Algorithm for assessing cardiovascular risk of surgery

Appendix B. Physician Action Algorithms — Proximal Humerus Fractures
Notes and abbreviations:

CVRF – cardiovascular risk factors (arterial hypertension, smoking, dyslipidemia (elevated total cholesterol >4.9 mmol/L and/or LDL cholesterol >3 mmol/L and/or HDL cholesterol <1.0 mmol/L in men, <1.2 mmol/L in women, and/or triglycerides >1.7 mmol/L), diabetes mellitus, family history of premature cardiovascular disease (<55 years for men and <65 years for women);

CVD – cardiovascular disease (coronary artery disease, cerebrovascular disease, peripheral artery disease, chronic heart failure, pulmonary hypertension, valvular heart disease, cardiomyopathies);

rRCRI - reconstructed RCRI index (See Appendix G2);

FS – functional status (the patient's ability to climb 2 flights of stairs independently without stopping before the injury).

*- regional vascular center or specialized cardiological department.

Appendix C. Patient Information

Humeral shaft fractures are injuries requiring specialized treatment in a trauma center or traumatology department. Conservative treatment of such injuries is only possible for fractures without fragment displacement. This type of treatment involves prolonged immobilization with a plaster cast or its alternatives. Its main drawback is the deterioration of quality of life and the need for prolonged rehabilitation, as immobilization may result in contracture of the shoulder and elbow joints. Surgical treatment is indicated for all fractures with fragment displacement. Various plate configurations, intramedullary nails, and external fixation devices in various configurations can be used to treat humeral shaft fractures. Treatment can be single-stage (for isolated closed fractures and satisfactory soft tissue condition) and two-stage, where the fracture is first temporarily fixed with an external fixator followed by conversion to internal fixation (in multiple and polytrauma, severe open fractures, and significant soft tissue injury). For these fractures, complete restoration of the injured bone anatomy is not required; restoring the axis, limb length, and eliminating rotational displacement is sufficient. In most cases, minimally invasive osteosynthesis techniques that do not involve opening the fracture site are used for this purpose. In all cases, the goal should be to achieve stable osteosynthesis that does not require additional external immobilization after surgery. This allows for early rehabilitation treatment.

Rehabilitation treatment should begin immediately after surgery. It consists of passive and active movements in the upper extremity joints, physiotherapeutic procedures, and exercises aimed at normalizing the trophic state of the injured soft tissues and bone. The timing of limb load-bearing may vary depending on the fracture pattern and fixation method. As a rule, following intramedullary osteosynthesis of extra-articular fractures, functional loading of the limb is permitted in the first days post-surgery. Following osteosynthesis of similar fractures with plates, the timing of axial loading depends on the complexity of the fracture, though functional joint movements in the injured upper extremity are possible in the first days after surgery.

Appendix G. Assessment Scales, Questionnaires, and Other Evaluation Tools

Appendix G1. QuickDASH upper extremity disability questionnaire

Russian title: The shortened disabilities of the arm, shoulder and hand questionnaire.

Original title: The shortened disabilities of the arm, shoulder and hand questionnaire (Quick DASH)

Source: Quick DASH Outcome Measures: Russian translation. Institute for Work & Health, 2006. https: //dash.iwh.on.ca /available-translations

Type: questionnaire

Purpose: assessment of the impact of musculoskeletal injuries and diseases on upper extremity function.

Content:

INSTRUCTIONS: This questionnaire asks about your symptoms as well as your ability to perform certain activities. Please answer each question based on your condition over the past week by circling the appropriate number. If you did not have the opportunity to perform a specific activity last week, please choose the most appropriate response. It does not matter which hand you use to perform the action; please answer based on your ability, regardless of how you independently perform the task.

Please rate your ability to do the following activities in the past week by circling the number of the appropriate response

not at all difficult

mild difficulty

somewhat difficult

very difficult

Unable

1. Open a tight or new jar

1

2

3

4

5

2. Do heavy household chores (e.g., wash walls, floors)

1

2

3

4

5

3. Carry a shopping bag or briefcase

1

2

3

4

5

4. Wash your back

1

2

3

4

5

5. Cut food with a knife

1

2

3

4

5

6. Recreational activities in which you take some force or impact through your arm, shoulder or hand (e.g., tennis, hammering, slamming a door)

1

2

3

4

5

not at all

a little bit

moderately

quite a bit

extremely

7. During the past week, to what extent has your arm, shoulder or hand problem interfered with your normal social activities with family, friends, neighbours or groups?

1

2

3

4

5

No limitation

mild

moderately

quite a bit

Unable

8. During the past week, were you limited in your work or other regular daily activities as a result of your arm, shoulder or hand problem?

1

2

3

4

5

Please rate the severity of the following symptoms in the past week:

none

mild

moderate

quite a bit

Extremely

9. Arm, shoulder or hand pain

1

2

3

4

5

10. Tingling (pins and needles) in your arm, shoulder or hand

1

2

3

4

5

not at all difficult

mild difficulty

somewhat difficult

very difficult

So difficult that I cannot sleep

11. During the past week, how much difficulty have you had sleeping because of the pain in your arm, shoulder or hand?

1

2

3

4

5

QuickDASH disability/symptom score = ([sum of n responses]/n - 1) × 25, where n is the number of completed responses.

The QuickDASH score cannot be calculated if more than 1 item is missed.

WORK MODULE (OPTIONAL)

The following questions ask about the impact of your arm, shoulder or hand problem on your ability to work (including homemaking if that is your main work).

Please indicate what your job/work is: ___________________________________________

I do not work. (You may skip this section).

Please circle the number that best describes your physical ability in the past week.

Did you have any difficulty:

not at all difficult

mild difficulty

somewhat difficult

very difficult

Unab- le

1. Using your usual technique for your work?

1

2

3

4

5

2. Doing your usual work because of arm, shoulder or hand pain?

1

2

3

4

5

3. Doing your work as well as you would like?

1

2

3

4

5

4. Spending your usual amount of time doing your work?

1

2

3

4

5

COMPETITIVE ATHLETES / MUSICIANS (OPTIONAL)

The following questions relate to the impact of your arm, shoulder or hand problem on playing your musical instrument or sport. If you play more than one sport or instrument (or do both), please answer with respect to that activity which is most important to you. Please indicate the sport or instrument which is most important to you: _________________________________________________________________________________

I do not play a sport or a musical instrument. (You may skip this section).

Please circle the number that best describes your physical ability in the past week.

not at all difficult

mild difficulty

somewhat difficult

very difficult

Unab- le

1. Using your usual technique for playing your instrument or sport?

1

2

3

4

5

2. Playing your musical instrument or sport because of arm, shoulder or hand pain?

1

2

3

4

5

3. Playing your musical instrument or sport as well as you would like?

1

2

3

4

5

4. Spending your usual amount of time practising or playing your instrument or sport?

1

2

3

4

5

OPTIONAL MODULE SCALING. All 4 questions must be answered. Simply add the assigned values for each response and divide by 4 (number of items); subtract 1 and multiply by 25.

Appendix G2. Revised Cardiac Risk Index (rRCRI)

Russian title: Reconstructed Revised Cardiac Risk Index for noncardiac surgical procedures

Original title: Reconstructed Revised Cardiac Risk Index (rRCRI)

Source: Davis C., Tait G., Carroll J. et al. The Revised Cardiac Risk Index in the new millennium: a single-centre prospective cohort re-evaluation of the original variables in 9,519 consecutive elective surgical patients. Can. J. Anaesth. 2013; 60(9): 855-863.

Type: scale

Purpose: prediction of the risk of perioperative cardiac complications in noncardiac surgery: myocardial infarction, pulmonary edema, ventricular fibrillation or cardiac arrest, complete AV block.

Content:

1. High-risk surgery (intrathoracic, intra-abdominal, or vascular surgery above the groin) - 1 point.

2. Coronary artery disease (myocardial infarction, positive stress test, angina, use of nitroglycerin, pathological Q wave on ECG) - 1 point.

3. Heart failure (history of heart failure, pulmonary edema, paroxysmal nocturnal dyspnea, bilateral rales, gallop rhythm, pulmonary congestion on chest X-ray) - 1 point.

4. TIA/Stroke - 1 point.

5. Creatinine clearance <30 mL/min - 1 point

Scoring:

  • total score of 0 – low risk of cardiovascular complications;

  • a total score of 1 – moderate risk of cardiovascular complications;

  • a total score of 2 or more – high risk of cardiovascular complications.

Notes:

The RCRI index was developed in 1977 [114] to predict the risk of perioperative cardiac complications in non-cardiac surgery. It was validated in the Lee study [115], and in 2013 [116] it was revised and re-validated based on clinical risk factors (replacing the criterion "creatinine level >176.8 µmol/L" with "creatinine clearance <30 mL/min"; the clinical criterion "insulin-dependent diabetes mellitus" was removed), hence it is called the reconstructed index. It includes 5 parameters, each assigned 1 point. This specific version of the index is recommended by the Russian Society of Cardiology [15].

Scales and calculators from this guideline

QuickDASHShortened Disabilities of the Arm, Shoulder and Hand questionnaireRevised Cardiac Risk Index (rRCRI)Risk of cardiac complications in non-cardiac surgery (revised)Modified Rankin Scale (mRS)Assessment of disability after stroke

If you practice in traumatology and orthopedics

ClinRevs Pro690 ₽ per month · cancel anytime

Clinical calculators and scalesRisk calculation, dosing, and scoring using scales from clinical guidelines — online, no registration required.

Open calculators

Answers based on Russian clinical guidelines right in ChatGPT and Claude Connect the WhiteCoat Pro connector, and the assistant will answer based on the "Proximal Humeral Fractures" guidelines and other active Russian Ministry of Health CPGs with a reference to the specific section, rather than paraphrasing foreign guidelines. Address: mcp.pervoklassno.ru/mcp. How to set up ChatGPT, Claude, Gemini, and Perplexity for Russian CPGs

Subscribe in 2 minutes

AI Research DigestEvery morning — fresh PubMed articles in your specialty: translation, AI analysis, and link to the original. Reads in four minutes.

Subscribe for 990 ₽

Related clinical guidelines